cohortDefinitionId,ruleSequence,name
211100000,0,No prior with-in class exposure
211100000,1,No prior DPP4 inhibitor exposure
211100000,2,No prior SGLT-2 inhibitor exposure
211100000,3,No prior SU exposure
211100000,4,No prior other anti-diabetic exposure
211100000,5,Prior metformin use
211100000,6,No prior insulin use or combo initiation
211110000,0,No prior with-in class exposure
211110000,1,No prior DPP4 inhibitor exposure
211110000,2,No prior SGLT-2 inhibitor exposure
211110000,3,No prior SU exposure
211110000,4,No prior other anti-diabetic exposure
211110000,5,Lower age group
211110000,6,Prior metformin use
211110000,7,No prior insulin use or combo initiation
211120000,0,No prior with-in class exposure
211120000,1,No prior DPP4 inhibitor exposure
211120000,2,No prior SGLT-2 inhibitor exposure
211120000,3,No prior SU exposure
211120000,4,No prior other anti-diabetic exposure
211120000,5,Middle age group
211120000,6,Prior metformin use
211120000,7,No prior insulin use or combo initiation
211130000,0,No prior with-in class exposure
211130000,1,No prior DPP4 inhibitor exposure
211130000,2,No prior SGLT-2 inhibitor exposure
211130000,3,No prior SU exposure
211130000,4,No prior other anti-diabetic exposure
211130000,5,Older age group
211130000,6,Prior metformin use
211130000,7,No prior insulin use or combo initiation
211100010,0,No prior with-in class exposure
211100010,1,No prior DPP4 inhibitor exposure
211100010,2,No prior SGLT-2 inhibitor exposure
211100010,3,No prior SU exposure
211100010,4,No prior other anti-diabetic exposure
211100010,5,Low cardiovascular risk
211100010,6,Prior metformin use
211100010,7,No prior insulin use or combo initiation
211100020,0,No prior with-in class exposure
211100020,1,No prior DPP4 inhibitor exposure
211100020,2,No prior SGLT-2 inhibitor exposure
211100020,3,No prior SU exposure
211100020,4,No prior other anti-diabetic exposure
211100020,5,Higher cardiovascular risk
211100020,6,Prior metformin use
211100020,7,No prior insulin use or combo initiation
211101000,0,No prior with-in class exposure
211101000,1,No prior DPP4 inhibitor exposure
211101000,2,No prior SGLT-2 inhibitor exposure
211101000,3,No prior SU exposure
211101000,4,No prior other anti-diabetic exposure
211101000,5,Female stratum
211101000,6,Prior metformin use
211101000,7,No prior insulin use or combo initiation
211102000,0,No prior with-in class exposure
211102000,1,No prior DPP4 inhibitor exposure
211102000,2,No prior SGLT-2 inhibitor exposure
211102000,3,No prior SU exposure
211102000,4,No prior other anti-diabetic exposure
211102000,5,Male stratum
211102000,6,Prior metformin use
211102000,7,No prior insulin use or combo initiation
211100100,0,No prior with-in class exposure
211100100,1,No prior DPP4 inhibitor exposure
211100100,2,No prior SGLT-2 inhibitor exposure
211100100,3,No prior SU exposure
211100100,4,No prior other anti-diabetic exposure
211100100,5,Race stratum
211100100,6,Prior metformin use
211100100,7,No prior insulin use or combo initiation
211100001,0,No prior with-in class exposure
211100001,1,No prior DPP4 inhibitor exposure
211100001,2,No prior SGLT-2 inhibitor exposure
211100001,3,No prior SU exposure
211100001,4,No prior other anti-diabetic exposure
211100001,5,Without renal impairment
211100001,6,Prior metformin use
211100001,7,No prior insulin use or combo initiation
211100002,0,No prior with-in class exposure
211100002,1,No prior DPP4 inhibitor exposure
211100002,2,No prior SGLT-2 inhibitor exposure
211100002,3,No prior SU exposure
211100002,4,No prior other anti-diabetic exposure
211100002,5,Renal impairment
211100002,6,Prior metformin use
211100002,7,No prior insulin use or combo initiation
212100000,0,No prior with-in class exposure
212100000,1,No prior DPP4 inhibitor exposure
212100000,2,No prior SGLT-2 inhibitor exposure
212100000,3,No prior SU exposure
212100000,4,No prior other anti-diabetic exposure
212100000,5,Prior metformin use
212100000,6,No prior insulin use or combo initiation
212110000,0,No prior with-in class exposure
212110000,1,No prior DPP4 inhibitor exposure
212110000,2,No prior SGLT-2 inhibitor exposure
212110000,3,No prior SU exposure
212110000,4,No prior other anti-diabetic exposure
212110000,5,Lower age group
212110000,6,Prior metformin use
212110000,7,No prior insulin use or combo initiation
212120000,0,No prior with-in class exposure
212120000,1,No prior DPP4 inhibitor exposure
212120000,2,No prior SGLT-2 inhibitor exposure
212120000,3,No prior SU exposure
212120000,4,No prior other anti-diabetic exposure
212120000,5,Middle age group
212120000,6,Prior metformin use
212120000,7,No prior insulin use or combo initiation
212130000,0,No prior with-in class exposure
212130000,1,No prior DPP4 inhibitor exposure
212130000,2,No prior SGLT-2 inhibitor exposure
212130000,3,No prior SU exposure
212130000,4,No prior other anti-diabetic exposure
212130000,5,Older age group
212130000,6,Prior metformin use
212130000,7,No prior insulin use or combo initiation
212100010,0,No prior with-in class exposure
212100010,1,No prior DPP4 inhibitor exposure
212100010,2,No prior SGLT-2 inhibitor exposure
212100010,3,No prior SU exposure
212100010,4,No prior other anti-diabetic exposure
212100010,5,Low cardiovascular risk
212100010,6,Prior metformin use
212100010,7,No prior insulin use or combo initiation
212100020,0,No prior with-in class exposure
212100020,1,No prior DPP4 inhibitor exposure
212100020,2,No prior SGLT-2 inhibitor exposure
212100020,3,No prior SU exposure
212100020,4,No prior other anti-diabetic exposure
212100020,5,Higher cardiovascular risk
212100020,6,Prior metformin use
212100020,7,No prior insulin use or combo initiation
212101000,0,No prior with-in class exposure
212101000,1,No prior DPP4 inhibitor exposure
212101000,2,No prior SGLT-2 inhibitor exposure
212101000,3,No prior SU exposure
212101000,4,No prior other anti-diabetic exposure
212101000,5,Female stratum
212101000,6,Prior metformin use
212101000,7,No prior insulin use or combo initiation
212102000,0,No prior with-in class exposure
212102000,1,No prior DPP4 inhibitor exposure
212102000,2,No prior SGLT-2 inhibitor exposure
212102000,3,No prior SU exposure
212102000,4,No prior other anti-diabetic exposure
212102000,5,Male stratum
212102000,6,Prior metformin use
212102000,7,No prior insulin use or combo initiation
212100100,0,No prior with-in class exposure
212100100,1,No prior DPP4 inhibitor exposure
212100100,2,No prior SGLT-2 inhibitor exposure
212100100,3,No prior SU exposure
212100100,4,No prior other anti-diabetic exposure
212100100,5,Race stratum
212100100,6,Prior metformin use
212100100,7,No prior insulin use or combo initiation
212100001,0,No prior with-in class exposure
212100001,1,No prior DPP4 inhibitor exposure
212100001,2,No prior SGLT-2 inhibitor exposure
212100001,3,No prior SU exposure
212100001,4,No prior other anti-diabetic exposure
212100001,5,Without renal impairment
212100001,6,Prior metformin use
212100001,7,No prior insulin use or combo initiation
212100002,0,No prior with-in class exposure
212100002,1,No prior DPP4 inhibitor exposure
212100002,2,No prior SGLT-2 inhibitor exposure
212100002,3,No prior SU exposure
212100002,4,No prior other anti-diabetic exposure
212100002,5,Renal impairment
212100002,6,Prior metformin use
212100002,7,No prior insulin use or combo initiation
211200000,0,No prior with-in class exposure
211200000,1,No prior DPP4 inhibitor exposure
211200000,2,No prior SGLT-2 inhibitor exposure
211200000,3,No prior SU exposure
211200000,4,No prior other anti-diabetic exposure
211200000,5,No prior metformin use
211200000,6,No prior insulin use or combo initiation
211210000,0,No prior with-in class exposure
211210000,1,No prior DPP4 inhibitor exposure
211210000,2,No prior SGLT-2 inhibitor exposure
211210000,3,No prior SU exposure
211210000,4,No prior other anti-diabetic exposure
211210000,5,Lower age group
211210000,6,No prior metformin use
211210000,7,No prior insulin use or combo initiation
211220000,0,No prior with-in class exposure
211220000,1,No prior DPP4 inhibitor exposure
211220000,2,No prior SGLT-2 inhibitor exposure
211220000,3,No prior SU exposure
211220000,4,No prior other anti-diabetic exposure
211220000,5,Middle age group
211220000,6,No prior metformin use
211220000,7,No prior insulin use or combo initiation
211230000,0,No prior with-in class exposure
211230000,1,No prior DPP4 inhibitor exposure
211230000,2,No prior SGLT-2 inhibitor exposure
211230000,3,No prior SU exposure
211230000,4,No prior other anti-diabetic exposure
211230000,5,Older age group
211230000,6,No prior metformin use
211230000,7,No prior insulin use or combo initiation
211200010,0,No prior with-in class exposure
211200010,1,No prior DPP4 inhibitor exposure
211200010,2,No prior SGLT-2 inhibitor exposure
211200010,3,No prior SU exposure
211200010,4,No prior other anti-diabetic exposure
211200010,5,Low cardiovascular risk
211200010,6,No prior metformin use
211200010,7,No prior insulin use or combo initiation
211200020,0,No prior with-in class exposure
211200020,1,No prior DPP4 inhibitor exposure
211200020,2,No prior SGLT-2 inhibitor exposure
211200020,3,No prior SU exposure
211200020,4,No prior other anti-diabetic exposure
211200020,5,Higher cardiovascular risk
211200020,6,No prior metformin use
211200020,7,No prior insulin use or combo initiation
211201000,0,No prior with-in class exposure
211201000,1,No prior DPP4 inhibitor exposure
211201000,2,No prior SGLT-2 inhibitor exposure
211201000,3,No prior SU exposure
211201000,4,No prior other anti-diabetic exposure
211201000,5,Female stratum
211201000,6,No prior metformin use
211201000,7,No prior insulin use or combo initiation
211202000,0,No prior with-in class exposure
211202000,1,No prior DPP4 inhibitor exposure
211202000,2,No prior SGLT-2 inhibitor exposure
211202000,3,No prior SU exposure
211202000,4,No prior other anti-diabetic exposure
211202000,5,Male stratum
211202000,6,No prior metformin use
211202000,7,No prior insulin use or combo initiation
211200100,0,No prior with-in class exposure
211200100,1,No prior DPP4 inhibitor exposure
211200100,2,No prior SGLT-2 inhibitor exposure
211200100,3,No prior SU exposure
211200100,4,No prior other anti-diabetic exposure
211200100,5,Race stratum
211200100,6,No prior metformin use
211200100,7,No prior insulin use or combo initiation
211200001,0,No prior with-in class exposure
211200001,1,No prior DPP4 inhibitor exposure
211200001,2,No prior SGLT-2 inhibitor exposure
211200001,3,No prior SU exposure
211200001,4,No prior other anti-diabetic exposure
211200001,5,Without renal impairment
211200001,6,No prior metformin use
211200001,7,No prior insulin use or combo initiation
211200002,0,No prior with-in class exposure
211200002,1,No prior DPP4 inhibitor exposure
211200002,2,No prior SGLT-2 inhibitor exposure
211200002,3,No prior SU exposure
211200002,4,No prior other anti-diabetic exposure
211200002,5,Renal impairment
211200002,6,No prior metformin use
211200002,7,No prior insulin use or combo initiation
212200000,0,No prior with-in class exposure
212200000,1,No prior DPP4 inhibitor exposure
212200000,2,No prior SGLT-2 inhibitor exposure
212200000,3,No prior SU exposure
212200000,4,No prior other anti-diabetic exposure
212200000,5,No prior metformin use
212200000,6,No prior insulin use or combo initiation
212210000,0,No prior with-in class exposure
212210000,1,No prior DPP4 inhibitor exposure
212210000,2,No prior SGLT-2 inhibitor exposure
212210000,3,No prior SU exposure
212210000,4,No prior other anti-diabetic exposure
212210000,5,Lower age group
212210000,6,No prior metformin use
212210000,7,No prior insulin use or combo initiation
212220000,0,No prior with-in class exposure
212220000,1,No prior DPP4 inhibitor exposure
212220000,2,No prior SGLT-2 inhibitor exposure
212220000,3,No prior SU exposure
212220000,4,No prior other anti-diabetic exposure
212220000,5,Middle age group
212220000,6,No prior metformin use
212220000,7,No prior insulin use or combo initiation
212230000,0,No prior with-in class exposure
212230000,1,No prior DPP4 inhibitor exposure
212230000,2,No prior SGLT-2 inhibitor exposure
212230000,3,No prior SU exposure
212230000,4,No prior other anti-diabetic exposure
212230000,5,Older age group
212230000,6,No prior metformin use
212230000,7,No prior insulin use or combo initiation
212200010,0,No prior with-in class exposure
212200010,1,No prior DPP4 inhibitor exposure
212200010,2,No prior SGLT-2 inhibitor exposure
212200010,3,No prior SU exposure
212200010,4,No prior other anti-diabetic exposure
212200010,5,Low cardiovascular risk
212200010,6,No prior metformin use
212200010,7,No prior insulin use or combo initiation
212200020,0,No prior with-in class exposure
212200020,1,No prior DPP4 inhibitor exposure
212200020,2,No prior SGLT-2 inhibitor exposure
212200020,3,No prior SU exposure
212200020,4,No prior other anti-diabetic exposure
212200020,5,Higher cardiovascular risk
212200020,6,No prior metformin use
212200020,7,No prior insulin use or combo initiation
212201000,0,No prior with-in class exposure
212201000,1,No prior DPP4 inhibitor exposure
212201000,2,No prior SGLT-2 inhibitor exposure
212201000,3,No prior SU exposure
212201000,4,No prior other anti-diabetic exposure
212201000,5,Female stratum
212201000,6,No prior metformin use
212201000,7,No prior insulin use or combo initiation
212202000,0,No prior with-in class exposure
212202000,1,No prior DPP4 inhibitor exposure
212202000,2,No prior SGLT-2 inhibitor exposure
212202000,3,No prior SU exposure
212202000,4,No prior other anti-diabetic exposure
212202000,5,Male stratum
212202000,6,No prior metformin use
212202000,7,No prior insulin use or combo initiation
212200100,0,No prior with-in class exposure
212200100,1,No prior DPP4 inhibitor exposure
212200100,2,No prior SGLT-2 inhibitor exposure
212200100,3,No prior SU exposure
212200100,4,No prior other anti-diabetic exposure
212200100,5,Race stratum
212200100,6,No prior metformin use
212200100,7,No prior insulin use or combo initiation
212200001,0,No prior with-in class exposure
212200001,1,No prior DPP4 inhibitor exposure
212200001,2,No prior SGLT-2 inhibitor exposure
212200001,3,No prior SU exposure
212200001,4,No prior other anti-diabetic exposure
212200001,5,Without renal impairment
212200001,6,No prior metformin use
212200001,7,No prior insulin use or combo initiation
212200002,0,No prior with-in class exposure
212200002,1,No prior DPP4 inhibitor exposure
212200002,2,No prior SGLT-2 inhibitor exposure
212200002,3,No prior SU exposure
212200002,4,No prior other anti-diabetic exposure
212200002,5,Renal impairment
212200002,6,No prior metformin use
212200002,7,No prior insulin use or combo initiation
221100000,0,No prior with-in class exposure
221100000,1,No prior DPP4 inhibitor exposure
221100000,2,No prior SGLT-2 inhibitor exposure
221100000,3,No prior SU exposure
221100000,4,No prior other anti-diabetic exposure
221100000,5,Prior metformin use
221100000,6,No prior insulin use or combo initiation
221110000,0,No prior with-in class exposure
221110000,1,No prior DPP4 inhibitor exposure
221110000,2,No prior SGLT-2 inhibitor exposure
221110000,3,No prior SU exposure
221110000,4,No prior other anti-diabetic exposure
221110000,5,Lower age group
221110000,6,Prior metformin use
221110000,7,No prior insulin use or combo initiation
221120000,0,No prior with-in class exposure
221120000,1,No prior DPP4 inhibitor exposure
221120000,2,No prior SGLT-2 inhibitor exposure
221120000,3,No prior SU exposure
221120000,4,No prior other anti-diabetic exposure
221120000,5,Middle age group
221120000,6,Prior metformin use
221120000,7,No prior insulin use or combo initiation
221130000,0,No prior with-in class exposure
221130000,1,No prior DPP4 inhibitor exposure
221130000,2,No prior SGLT-2 inhibitor exposure
221130000,3,No prior SU exposure
221130000,4,No prior other anti-diabetic exposure
221130000,5,Older age group
221130000,6,Prior metformin use
221130000,7,No prior insulin use or combo initiation
221100010,0,No prior with-in class exposure
221100010,1,No prior DPP4 inhibitor exposure
221100010,2,No prior SGLT-2 inhibitor exposure
221100010,3,No prior SU exposure
221100010,4,No prior other anti-diabetic exposure
221100010,5,Low cardiovascular risk
221100010,6,Prior metformin use
221100010,7,No prior insulin use or combo initiation
221100020,0,No prior with-in class exposure
221100020,1,No prior DPP4 inhibitor exposure
221100020,2,No prior SGLT-2 inhibitor exposure
221100020,3,No prior SU exposure
221100020,4,No prior other anti-diabetic exposure
221100020,5,Higher cardiovascular risk
221100020,6,Prior metformin use
221100020,7,No prior insulin use or combo initiation
221101000,0,No prior with-in class exposure
221101000,1,No prior DPP4 inhibitor exposure
221101000,2,No prior SGLT-2 inhibitor exposure
221101000,3,No prior SU exposure
221101000,4,No prior other anti-diabetic exposure
221101000,5,Female stratum
221101000,6,Prior metformin use
221101000,7,No prior insulin use or combo initiation
221102000,0,No prior with-in class exposure
221102000,1,No prior DPP4 inhibitor exposure
221102000,2,No prior SGLT-2 inhibitor exposure
221102000,3,No prior SU exposure
221102000,4,No prior other anti-diabetic exposure
221102000,5,Male stratum
221102000,6,Prior metformin use
221102000,7,No prior insulin use or combo initiation
221100100,0,No prior with-in class exposure
221100100,1,No prior DPP4 inhibitor exposure
221100100,2,No prior SGLT-2 inhibitor exposure
221100100,3,No prior SU exposure
221100100,4,No prior other anti-diabetic exposure
221100100,5,Race stratum
221100100,6,Prior metformin use
221100100,7,No prior insulin use or combo initiation
221100001,0,No prior with-in class exposure
221100001,1,No prior DPP4 inhibitor exposure
221100001,2,No prior SGLT-2 inhibitor exposure
221100001,3,No prior SU exposure
221100001,4,No prior other anti-diabetic exposure
221100001,5,Without renal impairment
221100001,6,Prior metformin use
221100001,7,No prior insulin use or combo initiation
221100002,0,No prior with-in class exposure
221100002,1,No prior DPP4 inhibitor exposure
221100002,2,No prior SGLT-2 inhibitor exposure
221100002,3,No prior SU exposure
221100002,4,No prior other anti-diabetic exposure
221100002,5,Renal impairment
221100002,6,Prior metformin use
221100002,7,No prior insulin use or combo initiation
222100000,0,No prior with-in class exposure
222100000,1,No prior DPP4 inhibitor exposure
222100000,2,No prior SGLT-2 inhibitor exposure
222100000,3,No prior SU exposure
222100000,4,No prior other anti-diabetic exposure
222100000,5,Prior metformin use
222100000,6,No prior insulin use or combo initiation
222110000,0,No prior with-in class exposure
222110000,1,No prior DPP4 inhibitor exposure
222110000,2,No prior SGLT-2 inhibitor exposure
222110000,3,No prior SU exposure
222110000,4,No prior other anti-diabetic exposure
222110000,5,Lower age group
222110000,6,Prior metformin use
222110000,7,No prior insulin use or combo initiation
222120000,0,No prior with-in class exposure
222120000,1,No prior DPP4 inhibitor exposure
222120000,2,No prior SGLT-2 inhibitor exposure
222120000,3,No prior SU exposure
222120000,4,No prior other anti-diabetic exposure
222120000,5,Middle age group
222120000,6,Prior metformin use
222120000,7,No prior insulin use or combo initiation
222130000,0,No prior with-in class exposure
222130000,1,No prior DPP4 inhibitor exposure
222130000,2,No prior SGLT-2 inhibitor exposure
222130000,3,No prior SU exposure
222130000,4,No prior other anti-diabetic exposure
222130000,5,Older age group
222130000,6,Prior metformin use
222130000,7,No prior insulin use or combo initiation
222100010,0,No prior with-in class exposure
222100010,1,No prior DPP4 inhibitor exposure
222100010,2,No prior SGLT-2 inhibitor exposure
222100010,3,No prior SU exposure
222100010,4,No prior other anti-diabetic exposure
222100010,5,Low cardiovascular risk
222100010,6,Prior metformin use
222100010,7,No prior insulin use or combo initiation
222100020,0,No prior with-in class exposure
222100020,1,No prior DPP4 inhibitor exposure
222100020,2,No prior SGLT-2 inhibitor exposure
222100020,3,No prior SU exposure
222100020,4,No prior other anti-diabetic exposure
222100020,5,Higher cardiovascular risk
222100020,6,Prior metformin use
222100020,7,No prior insulin use or combo initiation
222101000,0,No prior with-in class exposure
222101000,1,No prior DPP4 inhibitor exposure
222101000,2,No prior SGLT-2 inhibitor exposure
222101000,3,No prior SU exposure
222101000,4,No prior other anti-diabetic exposure
222101000,5,Female stratum
222101000,6,Prior metformin use
222101000,7,No prior insulin use or combo initiation
222102000,0,No prior with-in class exposure
222102000,1,No prior DPP4 inhibitor exposure
222102000,2,No prior SGLT-2 inhibitor exposure
222102000,3,No prior SU exposure
222102000,4,No prior other anti-diabetic exposure
222102000,5,Male stratum
222102000,6,Prior metformin use
222102000,7,No prior insulin use or combo initiation
222100100,0,No prior with-in class exposure
222100100,1,No prior DPP4 inhibitor exposure
222100100,2,No prior SGLT-2 inhibitor exposure
222100100,3,No prior SU exposure
222100100,4,No prior other anti-diabetic exposure
222100100,5,Race stratum
222100100,6,Prior metformin use
222100100,7,No prior insulin use or combo initiation
222100001,0,No prior with-in class exposure
222100001,1,No prior DPP4 inhibitor exposure
222100001,2,No prior SGLT-2 inhibitor exposure
222100001,3,No prior SU exposure
222100001,4,No prior other anti-diabetic exposure
222100001,5,Without renal impairment
222100001,6,Prior metformin use
222100001,7,No prior insulin use or combo initiation
222100002,0,No prior with-in class exposure
222100002,1,No prior DPP4 inhibitor exposure
222100002,2,No prior SGLT-2 inhibitor exposure
222100002,3,No prior SU exposure
222100002,4,No prior other anti-diabetic exposure
222100002,5,Renal impairment
222100002,6,Prior metformin use
222100002,7,No prior insulin use or combo initiation
221200000,0,No prior with-in class exposure
221200000,1,No prior DPP4 inhibitor exposure
221200000,2,No prior SGLT-2 inhibitor exposure
221200000,3,No prior SU exposure
221200000,4,No prior other anti-diabetic exposure
221200000,5,No prior metformin use
221200000,6,No prior insulin use or combo initiation
221210000,0,No prior with-in class exposure
221210000,1,No prior DPP4 inhibitor exposure
221210000,2,No prior SGLT-2 inhibitor exposure
221210000,3,No prior SU exposure
221210000,4,No prior other anti-diabetic exposure
221210000,5,Lower age group
221210000,6,No prior metformin use
221210000,7,No prior insulin use or combo initiation
221220000,0,No prior with-in class exposure
221220000,1,No prior DPP4 inhibitor exposure
221220000,2,No prior SGLT-2 inhibitor exposure
221220000,3,No prior SU exposure
221220000,4,No prior other anti-diabetic exposure
221220000,5,Middle age group
221220000,6,No prior metformin use
221220000,7,No prior insulin use or combo initiation
221230000,0,No prior with-in class exposure
221230000,1,No prior DPP4 inhibitor exposure
221230000,2,No prior SGLT-2 inhibitor exposure
221230000,3,No prior SU exposure
221230000,4,No prior other anti-diabetic exposure
221230000,5,Older age group
221230000,6,No prior metformin use
221230000,7,No prior insulin use or combo initiation
221200010,0,No prior with-in class exposure
221200010,1,No prior DPP4 inhibitor exposure
221200010,2,No prior SGLT-2 inhibitor exposure
221200010,3,No prior SU exposure
221200010,4,No prior other anti-diabetic exposure
221200010,5,Low cardiovascular risk
221200010,6,No prior metformin use
221200010,7,No prior insulin use or combo initiation
221200020,0,No prior with-in class exposure
221200020,1,No prior DPP4 inhibitor exposure
221200020,2,No prior SGLT-2 inhibitor exposure
221200020,3,No prior SU exposure
221200020,4,No prior other anti-diabetic exposure
221200020,5,Higher cardiovascular risk
221200020,6,No prior metformin use
221200020,7,No prior insulin use or combo initiation
221201000,0,No prior with-in class exposure
221201000,1,No prior DPP4 inhibitor exposure
221201000,2,No prior SGLT-2 inhibitor exposure
221201000,3,No prior SU exposure
221201000,4,No prior other anti-diabetic exposure
221201000,5,Female stratum
221201000,6,No prior metformin use
221201000,7,No prior insulin use or combo initiation
221202000,0,No prior with-in class exposure
221202000,1,No prior DPP4 inhibitor exposure
221202000,2,No prior SGLT-2 inhibitor exposure
221202000,3,No prior SU exposure
221202000,4,No prior other anti-diabetic exposure
221202000,5,Male stratum
221202000,6,No prior metformin use
221202000,7,No prior insulin use or combo initiation
221200100,0,No prior with-in class exposure
221200100,1,No prior DPP4 inhibitor exposure
221200100,2,No prior SGLT-2 inhibitor exposure
221200100,3,No prior SU exposure
221200100,4,No prior other anti-diabetic exposure
221200100,5,Race stratum
221200100,6,No prior metformin use
221200100,7,No prior insulin use or combo initiation
221200001,0,No prior with-in class exposure
221200001,1,No prior DPP4 inhibitor exposure
221200001,2,No prior SGLT-2 inhibitor exposure
221200001,3,No prior SU exposure
221200001,4,No prior other anti-diabetic exposure
221200001,5,Without renal impairment
221200001,6,No prior metformin use
221200001,7,No prior insulin use or combo initiation
221200002,0,No prior with-in class exposure
221200002,1,No prior DPP4 inhibitor exposure
221200002,2,No prior SGLT-2 inhibitor exposure
221200002,3,No prior SU exposure
221200002,4,No prior other anti-diabetic exposure
221200002,5,Renal impairment
221200002,6,No prior metformin use
221200002,7,No prior insulin use or combo initiation
222200000,0,No prior with-in class exposure
222200000,1,No prior DPP4 inhibitor exposure
222200000,2,No prior SGLT-2 inhibitor exposure
222200000,3,No prior SU exposure
222200000,4,No prior other anti-diabetic exposure
222200000,5,No prior metformin use
222200000,6,No prior insulin use or combo initiation
222210000,0,No prior with-in class exposure
222210000,1,No prior DPP4 inhibitor exposure
222210000,2,No prior SGLT-2 inhibitor exposure
222210000,3,No prior SU exposure
222210000,4,No prior other anti-diabetic exposure
222210000,5,Lower age group
222210000,6,No prior metformin use
222210000,7,No prior insulin use or combo initiation
222220000,0,No prior with-in class exposure
222220000,1,No prior DPP4 inhibitor exposure
222220000,2,No prior SGLT-2 inhibitor exposure
222220000,3,No prior SU exposure
222220000,4,No prior other anti-diabetic exposure
222220000,5,Middle age group
222220000,6,No prior metformin use
222220000,7,No prior insulin use or combo initiation
222230000,0,No prior with-in class exposure
222230000,1,No prior DPP4 inhibitor exposure
222230000,2,No prior SGLT-2 inhibitor exposure
222230000,3,No prior SU exposure
222230000,4,No prior other anti-diabetic exposure
222230000,5,Older age group
222230000,6,No prior metformin use
222230000,7,No prior insulin use or combo initiation
222200010,0,No prior with-in class exposure
222200010,1,No prior DPP4 inhibitor exposure
222200010,2,No prior SGLT-2 inhibitor exposure
222200010,3,No prior SU exposure
222200010,4,No prior other anti-diabetic exposure
222200010,5,Low cardiovascular risk
222200010,6,No prior metformin use
222200010,7,No prior insulin use or combo initiation
222200020,0,No prior with-in class exposure
222200020,1,No prior DPP4 inhibitor exposure
222200020,2,No prior SGLT-2 inhibitor exposure
222200020,3,No prior SU exposure
222200020,4,No prior other anti-diabetic exposure
222200020,5,Higher cardiovascular risk
222200020,6,No prior metformin use
222200020,7,No prior insulin use or combo initiation
222201000,0,No prior with-in class exposure
222201000,1,No prior DPP4 inhibitor exposure
222201000,2,No prior SGLT-2 inhibitor exposure
222201000,3,No prior SU exposure
222201000,4,No prior other anti-diabetic exposure
222201000,5,Female stratum
222201000,6,No prior metformin use
222201000,7,No prior insulin use or combo initiation
222202000,0,No prior with-in class exposure
222202000,1,No prior DPP4 inhibitor exposure
222202000,2,No prior SGLT-2 inhibitor exposure
222202000,3,No prior SU exposure
222202000,4,No prior other anti-diabetic exposure
222202000,5,Male stratum
222202000,6,No prior metformin use
222202000,7,No prior insulin use or combo initiation
222200100,0,No prior with-in class exposure
222200100,1,No prior DPP4 inhibitor exposure
222200100,2,No prior SGLT-2 inhibitor exposure
222200100,3,No prior SU exposure
222200100,4,No prior other anti-diabetic exposure
222200100,5,Race stratum
222200100,6,No prior metformin use
222200100,7,No prior insulin use or combo initiation
222200001,0,No prior with-in class exposure
222200001,1,No prior DPP4 inhibitor exposure
222200001,2,No prior SGLT-2 inhibitor exposure
222200001,3,No prior SU exposure
222200001,4,No prior other anti-diabetic exposure
222200001,5,Without renal impairment
222200001,6,No prior metformin use
222200001,7,No prior insulin use or combo initiation
222200002,0,No prior with-in class exposure
222200002,1,No prior DPP4 inhibitor exposure
222200002,2,No prior SGLT-2 inhibitor exposure
222200002,3,No prior SU exposure
222200002,4,No prior other anti-diabetic exposure
222200002,5,Renal impairment
222200002,6,No prior metformin use
222200002,7,No prior insulin use or combo initiation
231100000,0,No prior with-in class exposure
231100000,1,No prior DPP4 inhibitor exposure
231100000,2,No prior SGLT-2 inhibitor exposure
231100000,3,No prior SU exposure
231100000,4,No prior other anti-diabetic exposure
231100000,5,Prior metformin use
231100000,6,No prior insulin use or combo initiation
231110000,0,No prior with-in class exposure
231110000,1,No prior DPP4 inhibitor exposure
231110000,2,No prior SGLT-2 inhibitor exposure
231110000,3,No prior SU exposure
231110000,4,No prior other anti-diabetic exposure
231110000,5,Lower age group
231110000,6,Prior metformin use
231110000,7,No prior insulin use or combo initiation
231120000,0,No prior with-in class exposure
231120000,1,No prior DPP4 inhibitor exposure
231120000,2,No prior SGLT-2 inhibitor exposure
231120000,3,No prior SU exposure
231120000,4,No prior other anti-diabetic exposure
231120000,5,Middle age group
231120000,6,Prior metformin use
231120000,7,No prior insulin use or combo initiation
231130000,0,No prior with-in class exposure
231130000,1,No prior DPP4 inhibitor exposure
231130000,2,No prior SGLT-2 inhibitor exposure
231130000,3,No prior SU exposure
231130000,4,No prior other anti-diabetic exposure
231130000,5,Older age group
231130000,6,Prior metformin use
231130000,7,No prior insulin use or combo initiation
231100010,0,No prior with-in class exposure
231100010,1,No prior DPP4 inhibitor exposure
231100010,2,No prior SGLT-2 inhibitor exposure
231100010,3,No prior SU exposure
231100010,4,No prior other anti-diabetic exposure
231100010,5,Low cardiovascular risk
231100010,6,Prior metformin use
231100010,7,No prior insulin use or combo initiation
231100020,0,No prior with-in class exposure
231100020,1,No prior DPP4 inhibitor exposure
231100020,2,No prior SGLT-2 inhibitor exposure
231100020,3,No prior SU exposure
231100020,4,No prior other anti-diabetic exposure
231100020,5,Higher cardiovascular risk
231100020,6,Prior metformin use
231100020,7,No prior insulin use or combo initiation
231101000,0,No prior with-in class exposure
231101000,1,No prior DPP4 inhibitor exposure
231101000,2,No prior SGLT-2 inhibitor exposure
231101000,3,No prior SU exposure
231101000,4,No prior other anti-diabetic exposure
231101000,5,Female stratum
231101000,6,Prior metformin use
231101000,7,No prior insulin use or combo initiation
231102000,0,No prior with-in class exposure
231102000,1,No prior DPP4 inhibitor exposure
231102000,2,No prior SGLT-2 inhibitor exposure
231102000,3,No prior SU exposure
231102000,4,No prior other anti-diabetic exposure
231102000,5,Male stratum
231102000,6,Prior metformin use
231102000,7,No prior insulin use or combo initiation
231100100,0,No prior with-in class exposure
231100100,1,No prior DPP4 inhibitor exposure
231100100,2,No prior SGLT-2 inhibitor exposure
231100100,3,No prior SU exposure
231100100,4,No prior other anti-diabetic exposure
231100100,5,Race stratum
231100100,6,Prior metformin use
231100100,7,No prior insulin use or combo initiation
231100001,0,No prior with-in class exposure
231100001,1,No prior DPP4 inhibitor exposure
231100001,2,No prior SGLT-2 inhibitor exposure
231100001,3,No prior SU exposure
231100001,4,No prior other anti-diabetic exposure
231100001,5,Without renal impairment
231100001,6,Prior metformin use
231100001,7,No prior insulin use or combo initiation
231100002,0,No prior with-in class exposure
231100002,1,No prior DPP4 inhibitor exposure
231100002,2,No prior SGLT-2 inhibitor exposure
231100002,3,No prior SU exposure
231100002,4,No prior other anti-diabetic exposure
231100002,5,Renal impairment
231100002,6,Prior metformin use
231100002,7,No prior insulin use or combo initiation
232100000,0,No prior with-in class exposure
232100000,1,No prior DPP4 inhibitor exposure
232100000,2,No prior SGLT-2 inhibitor exposure
232100000,3,No prior SU exposure
232100000,4,No prior other anti-diabetic exposure
232100000,5,Prior metformin use
232100000,6,No prior insulin use or combo initiation
232110000,0,No prior with-in class exposure
232110000,1,No prior DPP4 inhibitor exposure
232110000,2,No prior SGLT-2 inhibitor exposure
232110000,3,No prior SU exposure
232110000,4,No prior other anti-diabetic exposure
232110000,5,Lower age group
232110000,6,Prior metformin use
232110000,7,No prior insulin use or combo initiation
232120000,0,No prior with-in class exposure
232120000,1,No prior DPP4 inhibitor exposure
232120000,2,No prior SGLT-2 inhibitor exposure
232120000,3,No prior SU exposure
232120000,4,No prior other anti-diabetic exposure
232120000,5,Middle age group
232120000,6,Prior metformin use
232120000,7,No prior insulin use or combo initiation
232130000,0,No prior with-in class exposure
232130000,1,No prior DPP4 inhibitor exposure
232130000,2,No prior SGLT-2 inhibitor exposure
232130000,3,No prior SU exposure
232130000,4,No prior other anti-diabetic exposure
232130000,5,Older age group
232130000,6,Prior metformin use
232130000,7,No prior insulin use or combo initiation
232100010,0,No prior with-in class exposure
232100010,1,No prior DPP4 inhibitor exposure
232100010,2,No prior SGLT-2 inhibitor exposure
232100010,3,No prior SU exposure
232100010,4,No prior other anti-diabetic exposure
232100010,5,Low cardiovascular risk
232100010,6,Prior metformin use
232100010,7,No prior insulin use or combo initiation
232100020,0,No prior with-in class exposure
232100020,1,No prior DPP4 inhibitor exposure
232100020,2,No prior SGLT-2 inhibitor exposure
232100020,3,No prior SU exposure
232100020,4,No prior other anti-diabetic exposure
232100020,5,Higher cardiovascular risk
232100020,6,Prior metformin use
232100020,7,No prior insulin use or combo initiation
232101000,0,No prior with-in class exposure
232101000,1,No prior DPP4 inhibitor exposure
232101000,2,No prior SGLT-2 inhibitor exposure
232101000,3,No prior SU exposure
232101000,4,No prior other anti-diabetic exposure
232101000,5,Female stratum
232101000,6,Prior metformin use
232101000,7,No prior insulin use or combo initiation
232102000,0,No prior with-in class exposure
232102000,1,No prior DPP4 inhibitor exposure
232102000,2,No prior SGLT-2 inhibitor exposure
232102000,3,No prior SU exposure
232102000,4,No prior other anti-diabetic exposure
232102000,5,Male stratum
232102000,6,Prior metformin use
232102000,7,No prior insulin use or combo initiation
232100100,0,No prior with-in class exposure
232100100,1,No prior DPP4 inhibitor exposure
232100100,2,No prior SGLT-2 inhibitor exposure
232100100,3,No prior SU exposure
232100100,4,No prior other anti-diabetic exposure
232100100,5,Race stratum
232100100,6,Prior metformin use
232100100,7,No prior insulin use or combo initiation
232100001,0,No prior with-in class exposure
232100001,1,No prior DPP4 inhibitor exposure
232100001,2,No prior SGLT-2 inhibitor exposure
232100001,3,No prior SU exposure
232100001,4,No prior other anti-diabetic exposure
232100001,5,Without renal impairment
232100001,6,Prior metformin use
232100001,7,No prior insulin use or combo initiation
232100002,0,No prior with-in class exposure
232100002,1,No prior DPP4 inhibitor exposure
232100002,2,No prior SGLT-2 inhibitor exposure
232100002,3,No prior SU exposure
232100002,4,No prior other anti-diabetic exposure
232100002,5,Renal impairment
232100002,6,Prior metformin use
232100002,7,No prior insulin use or combo initiation
231200000,0,No prior with-in class exposure
231200000,1,No prior DPP4 inhibitor exposure
231200000,2,No prior SGLT-2 inhibitor exposure
231200000,3,No prior SU exposure
231200000,4,No prior other anti-diabetic exposure
231200000,5,No prior metformin use
231200000,6,No prior insulin use or combo initiation
231210000,0,No prior with-in class exposure
231210000,1,No prior DPP4 inhibitor exposure
231210000,2,No prior SGLT-2 inhibitor exposure
231210000,3,No prior SU exposure
231210000,4,No prior other anti-diabetic exposure
231210000,5,Lower age group
231210000,6,No prior metformin use
231210000,7,No prior insulin use or combo initiation
231220000,0,No prior with-in class exposure
231220000,1,No prior DPP4 inhibitor exposure
231220000,2,No prior SGLT-2 inhibitor exposure
231220000,3,No prior SU exposure
231220000,4,No prior other anti-diabetic exposure
231220000,5,Middle age group
231220000,6,No prior metformin use
231220000,7,No prior insulin use or combo initiation
231230000,0,No prior with-in class exposure
231230000,1,No prior DPP4 inhibitor exposure
231230000,2,No prior SGLT-2 inhibitor exposure
231230000,3,No prior SU exposure
231230000,4,No prior other anti-diabetic exposure
231230000,5,Older age group
231230000,6,No prior metformin use
231230000,7,No prior insulin use or combo initiation
231200010,0,No prior with-in class exposure
231200010,1,No prior DPP4 inhibitor exposure
231200010,2,No prior SGLT-2 inhibitor exposure
231200010,3,No prior SU exposure
231200010,4,No prior other anti-diabetic exposure
231200010,5,Low cardiovascular risk
231200010,6,No prior metformin use
231200010,7,No prior insulin use or combo initiation
231200020,0,No prior with-in class exposure
231200020,1,No prior DPP4 inhibitor exposure
231200020,2,No prior SGLT-2 inhibitor exposure
231200020,3,No prior SU exposure
231200020,4,No prior other anti-diabetic exposure
231200020,5,Higher cardiovascular risk
231200020,6,No prior metformin use
231200020,7,No prior insulin use or combo initiation
231201000,0,No prior with-in class exposure
231201000,1,No prior DPP4 inhibitor exposure
231201000,2,No prior SGLT-2 inhibitor exposure
231201000,3,No prior SU exposure
231201000,4,No prior other anti-diabetic exposure
231201000,5,Female stratum
231201000,6,No prior metformin use
231201000,7,No prior insulin use or combo initiation
231202000,0,No prior with-in class exposure
231202000,1,No prior DPP4 inhibitor exposure
231202000,2,No prior SGLT-2 inhibitor exposure
231202000,3,No prior SU exposure
231202000,4,No prior other anti-diabetic exposure
231202000,5,Male stratum
231202000,6,No prior metformin use
231202000,7,No prior insulin use or combo initiation
231200100,0,No prior with-in class exposure
231200100,1,No prior DPP4 inhibitor exposure
231200100,2,No prior SGLT-2 inhibitor exposure
231200100,3,No prior SU exposure
231200100,4,No prior other anti-diabetic exposure
231200100,5,Race stratum
231200100,6,No prior metformin use
231200100,7,No prior insulin use or combo initiation
231200001,0,No prior with-in class exposure
231200001,1,No prior DPP4 inhibitor exposure
231200001,2,No prior SGLT-2 inhibitor exposure
231200001,3,No prior SU exposure
231200001,4,No prior other anti-diabetic exposure
231200001,5,Without renal impairment
231200001,6,No prior metformin use
231200001,7,No prior insulin use or combo initiation
231200002,0,No prior with-in class exposure
231200002,1,No prior DPP4 inhibitor exposure
231200002,2,No prior SGLT-2 inhibitor exposure
231200002,3,No prior SU exposure
231200002,4,No prior other anti-diabetic exposure
231200002,5,Renal impairment
231200002,6,No prior metformin use
231200002,7,No prior insulin use or combo initiation
232200000,0,No prior with-in class exposure
232200000,1,No prior DPP4 inhibitor exposure
232200000,2,No prior SGLT-2 inhibitor exposure
232200000,3,No prior SU exposure
232200000,4,No prior other anti-diabetic exposure
232200000,5,No prior metformin use
232200000,6,No prior insulin use or combo initiation
232210000,0,No prior with-in class exposure
232210000,1,No prior DPP4 inhibitor exposure
232210000,2,No prior SGLT-2 inhibitor exposure
232210000,3,No prior SU exposure
232210000,4,No prior other anti-diabetic exposure
232210000,5,Lower age group
232210000,6,No prior metformin use
232210000,7,No prior insulin use or combo initiation
232220000,0,No prior with-in class exposure
232220000,1,No prior DPP4 inhibitor exposure
232220000,2,No prior SGLT-2 inhibitor exposure
232220000,3,No prior SU exposure
232220000,4,No prior other anti-diabetic exposure
232220000,5,Middle age group
232220000,6,No prior metformin use
232220000,7,No prior insulin use or combo initiation
232230000,0,No prior with-in class exposure
232230000,1,No prior DPP4 inhibitor exposure
232230000,2,No prior SGLT-2 inhibitor exposure
232230000,3,No prior SU exposure
232230000,4,No prior other anti-diabetic exposure
232230000,5,Older age group
232230000,6,No prior metformin use
232230000,7,No prior insulin use or combo initiation
232200010,0,No prior with-in class exposure
232200010,1,No prior DPP4 inhibitor exposure
232200010,2,No prior SGLT-2 inhibitor exposure
232200010,3,No prior SU exposure
232200010,4,No prior other anti-diabetic exposure
232200010,5,Low cardiovascular risk
232200010,6,No prior metformin use
232200010,7,No prior insulin use or combo initiation
232200020,0,No prior with-in class exposure
232200020,1,No prior DPP4 inhibitor exposure
232200020,2,No prior SGLT-2 inhibitor exposure
232200020,3,No prior SU exposure
232200020,4,No prior other anti-diabetic exposure
232200020,5,Higher cardiovascular risk
232200020,6,No prior metformin use
232200020,7,No prior insulin use or combo initiation
232201000,0,No prior with-in class exposure
232201000,1,No prior DPP4 inhibitor exposure
232201000,2,No prior SGLT-2 inhibitor exposure
232201000,3,No prior SU exposure
232201000,4,No prior other anti-diabetic exposure
232201000,5,Female stratum
232201000,6,No prior metformin use
232201000,7,No prior insulin use or combo initiation
232202000,0,No prior with-in class exposure
232202000,1,No prior DPP4 inhibitor exposure
232202000,2,No prior SGLT-2 inhibitor exposure
232202000,3,No prior SU exposure
232202000,4,No prior other anti-diabetic exposure
232202000,5,Male stratum
232202000,6,No prior metformin use
232202000,7,No prior insulin use or combo initiation
232200100,0,No prior with-in class exposure
232200100,1,No prior DPP4 inhibitor exposure
232200100,2,No prior SGLT-2 inhibitor exposure
232200100,3,No prior SU exposure
232200100,4,No prior other anti-diabetic exposure
232200100,5,Race stratum
232200100,6,No prior metformin use
232200100,7,No prior insulin use or combo initiation
232200001,0,No prior with-in class exposure
232200001,1,No prior DPP4 inhibitor exposure
232200001,2,No prior SGLT-2 inhibitor exposure
232200001,3,No prior SU exposure
232200001,4,No prior other anti-diabetic exposure
232200001,5,Without renal impairment
232200001,6,No prior metformin use
232200001,7,No prior insulin use or combo initiation
232200002,0,No prior with-in class exposure
232200002,1,No prior DPP4 inhibitor exposure
232200002,2,No prior SGLT-2 inhibitor exposure
232200002,3,No prior SU exposure
232200002,4,No prior other anti-diabetic exposure
232200002,5,Renal impairment
232200002,6,No prior metformin use
232200002,7,No prior insulin use or combo initiation
241100000,0,No prior with-in class exposure
241100000,1,No prior DPP4 inhibitor exposure
241100000,2,No prior SGLT-2 inhibitor exposure
241100000,3,No prior SU exposure
241100000,4,No prior other anti-diabetic exposure
241100000,5,Prior metformin use
241100000,6,No prior insulin use or combo initiation
241110000,0,No prior with-in class exposure
241110000,1,No prior DPP4 inhibitor exposure
241110000,2,No prior SGLT-2 inhibitor exposure
241110000,3,No prior SU exposure
241110000,4,No prior other anti-diabetic exposure
241110000,5,Lower age group
241110000,6,Prior metformin use
241110000,7,No prior insulin use or combo initiation
241120000,0,No prior with-in class exposure
241120000,1,No prior DPP4 inhibitor exposure
241120000,2,No prior SGLT-2 inhibitor exposure
241120000,3,No prior SU exposure
241120000,4,No prior other anti-diabetic exposure
241120000,5,Middle age group
241120000,6,Prior metformin use
241120000,7,No prior insulin use or combo initiation
241130000,0,No prior with-in class exposure
241130000,1,No prior DPP4 inhibitor exposure
241130000,2,No prior SGLT-2 inhibitor exposure
241130000,3,No prior SU exposure
241130000,4,No prior other anti-diabetic exposure
241130000,5,Older age group
241130000,6,Prior metformin use
241130000,7,No prior insulin use or combo initiation
241100010,0,No prior with-in class exposure
241100010,1,No prior DPP4 inhibitor exposure
241100010,2,No prior SGLT-2 inhibitor exposure
241100010,3,No prior SU exposure
241100010,4,No prior other anti-diabetic exposure
241100010,5,Low cardiovascular risk
241100010,6,Prior metformin use
241100010,7,No prior insulin use or combo initiation
241100020,0,No prior with-in class exposure
241100020,1,No prior DPP4 inhibitor exposure
241100020,2,No prior SGLT-2 inhibitor exposure
241100020,3,No prior SU exposure
241100020,4,No prior other anti-diabetic exposure
241100020,5,Higher cardiovascular risk
241100020,6,Prior metformin use
241100020,7,No prior insulin use or combo initiation
241101000,0,No prior with-in class exposure
241101000,1,No prior DPP4 inhibitor exposure
241101000,2,No prior SGLT-2 inhibitor exposure
241101000,3,No prior SU exposure
241101000,4,No prior other anti-diabetic exposure
241101000,5,Female stratum
241101000,6,Prior metformin use
241101000,7,No prior insulin use or combo initiation
241102000,0,No prior with-in class exposure
241102000,1,No prior DPP4 inhibitor exposure
241102000,2,No prior SGLT-2 inhibitor exposure
241102000,3,No prior SU exposure
241102000,4,No prior other anti-diabetic exposure
241102000,5,Male stratum
241102000,6,Prior metformin use
241102000,7,No prior insulin use or combo initiation
241100100,0,No prior with-in class exposure
241100100,1,No prior DPP4 inhibitor exposure
241100100,2,No prior SGLT-2 inhibitor exposure
241100100,3,No prior SU exposure
241100100,4,No prior other anti-diabetic exposure
241100100,5,Race stratum
241100100,6,Prior metformin use
241100100,7,No prior insulin use or combo initiation
241100001,0,No prior with-in class exposure
241100001,1,No prior DPP4 inhibitor exposure
241100001,2,No prior SGLT-2 inhibitor exposure
241100001,3,No prior SU exposure
241100001,4,No prior other anti-diabetic exposure
241100001,5,Without renal impairment
241100001,6,Prior metformin use
241100001,7,No prior insulin use or combo initiation
241100002,0,No prior with-in class exposure
241100002,1,No prior DPP4 inhibitor exposure
241100002,2,No prior SGLT-2 inhibitor exposure
241100002,3,No prior SU exposure
241100002,4,No prior other anti-diabetic exposure
241100002,5,Renal impairment
241100002,6,Prior metformin use
241100002,7,No prior insulin use or combo initiation
242100000,0,No prior with-in class exposure
242100000,1,No prior DPP4 inhibitor exposure
242100000,2,No prior SGLT-2 inhibitor exposure
242100000,3,No prior SU exposure
242100000,4,No prior other anti-diabetic exposure
242100000,5,Prior metformin use
242100000,6,No prior insulin use or combo initiation
242110000,0,No prior with-in class exposure
242110000,1,No prior DPP4 inhibitor exposure
242110000,2,No prior SGLT-2 inhibitor exposure
242110000,3,No prior SU exposure
242110000,4,No prior other anti-diabetic exposure
242110000,5,Lower age group
242110000,6,Prior metformin use
242110000,7,No prior insulin use or combo initiation
242120000,0,No prior with-in class exposure
242120000,1,No prior DPP4 inhibitor exposure
242120000,2,No prior SGLT-2 inhibitor exposure
242120000,3,No prior SU exposure
242120000,4,No prior other anti-diabetic exposure
242120000,5,Middle age group
242120000,6,Prior metformin use
242120000,7,No prior insulin use or combo initiation
242130000,0,No prior with-in class exposure
242130000,1,No prior DPP4 inhibitor exposure
242130000,2,No prior SGLT-2 inhibitor exposure
242130000,3,No prior SU exposure
242130000,4,No prior other anti-diabetic exposure
242130000,5,Older age group
242130000,6,Prior metformin use
242130000,7,No prior insulin use or combo initiation
242100010,0,No prior with-in class exposure
242100010,1,No prior DPP4 inhibitor exposure
242100010,2,No prior SGLT-2 inhibitor exposure
242100010,3,No prior SU exposure
242100010,4,No prior other anti-diabetic exposure
242100010,5,Low cardiovascular risk
242100010,6,Prior metformin use
242100010,7,No prior insulin use or combo initiation
242100020,0,No prior with-in class exposure
242100020,1,No prior DPP4 inhibitor exposure
242100020,2,No prior SGLT-2 inhibitor exposure
242100020,3,No prior SU exposure
242100020,4,No prior other anti-diabetic exposure
242100020,5,Higher cardiovascular risk
242100020,6,Prior metformin use
242100020,7,No prior insulin use or combo initiation
242101000,0,No prior with-in class exposure
242101000,1,No prior DPP4 inhibitor exposure
242101000,2,No prior SGLT-2 inhibitor exposure
242101000,3,No prior SU exposure
242101000,4,No prior other anti-diabetic exposure
242101000,5,Female stratum
242101000,6,Prior metformin use
242101000,7,No prior insulin use or combo initiation
242102000,0,No prior with-in class exposure
242102000,1,No prior DPP4 inhibitor exposure
242102000,2,No prior SGLT-2 inhibitor exposure
242102000,3,No prior SU exposure
242102000,4,No prior other anti-diabetic exposure
242102000,5,Male stratum
242102000,6,Prior metformin use
242102000,7,No prior insulin use or combo initiation
242100100,0,No prior with-in class exposure
242100100,1,No prior DPP4 inhibitor exposure
242100100,2,No prior SGLT-2 inhibitor exposure
242100100,3,No prior SU exposure
242100100,4,No prior other anti-diabetic exposure
242100100,5,Race stratum
242100100,6,Prior metformin use
242100100,7,No prior insulin use or combo initiation
242100001,0,No prior with-in class exposure
242100001,1,No prior DPP4 inhibitor exposure
242100001,2,No prior SGLT-2 inhibitor exposure
242100001,3,No prior SU exposure
242100001,4,No prior other anti-diabetic exposure
242100001,5,Without renal impairment
242100001,6,Prior metformin use
242100001,7,No prior insulin use or combo initiation
242100002,0,No prior with-in class exposure
242100002,1,No prior DPP4 inhibitor exposure
242100002,2,No prior SGLT-2 inhibitor exposure
242100002,3,No prior SU exposure
242100002,4,No prior other anti-diabetic exposure
242100002,5,Renal impairment
242100002,6,Prior metformin use
242100002,7,No prior insulin use or combo initiation
241200000,0,No prior with-in class exposure
241200000,1,No prior DPP4 inhibitor exposure
241200000,2,No prior SGLT-2 inhibitor exposure
241200000,3,No prior SU exposure
241200000,4,No prior other anti-diabetic exposure
241200000,5,No prior metformin use
241200000,6,No prior insulin use or combo initiation
241210000,0,No prior with-in class exposure
241210000,1,No prior DPP4 inhibitor exposure
241210000,2,No prior SGLT-2 inhibitor exposure
241210000,3,No prior SU exposure
241210000,4,No prior other anti-diabetic exposure
241210000,5,Lower age group
241210000,6,No prior metformin use
241210000,7,No prior insulin use or combo initiation
241220000,0,No prior with-in class exposure
241220000,1,No prior DPP4 inhibitor exposure
241220000,2,No prior SGLT-2 inhibitor exposure
241220000,3,No prior SU exposure
241220000,4,No prior other anti-diabetic exposure
241220000,5,Middle age group
241220000,6,No prior metformin use
241220000,7,No prior insulin use or combo initiation
241230000,0,No prior with-in class exposure
241230000,1,No prior DPP4 inhibitor exposure
241230000,2,No prior SGLT-2 inhibitor exposure
241230000,3,No prior SU exposure
241230000,4,No prior other anti-diabetic exposure
241230000,5,Older age group
241230000,6,No prior metformin use
241230000,7,No prior insulin use or combo initiation
241200010,0,No prior with-in class exposure
241200010,1,No prior DPP4 inhibitor exposure
241200010,2,No prior SGLT-2 inhibitor exposure
241200010,3,No prior SU exposure
241200010,4,No prior other anti-diabetic exposure
241200010,5,Low cardiovascular risk
241200010,6,No prior metformin use
241200010,7,No prior insulin use or combo initiation
241200020,0,No prior with-in class exposure
241200020,1,No prior DPP4 inhibitor exposure
241200020,2,No prior SGLT-2 inhibitor exposure
241200020,3,No prior SU exposure
241200020,4,No prior other anti-diabetic exposure
241200020,5,Higher cardiovascular risk
241200020,6,No prior metformin use
241200020,7,No prior insulin use or combo initiation
241201000,0,No prior with-in class exposure
241201000,1,No prior DPP4 inhibitor exposure
241201000,2,No prior SGLT-2 inhibitor exposure
241201000,3,No prior SU exposure
241201000,4,No prior other anti-diabetic exposure
241201000,5,Female stratum
241201000,6,No prior metformin use
241201000,7,No prior insulin use or combo initiation
241202000,0,No prior with-in class exposure
241202000,1,No prior DPP4 inhibitor exposure
241202000,2,No prior SGLT-2 inhibitor exposure
241202000,3,No prior SU exposure
241202000,4,No prior other anti-diabetic exposure
241202000,5,Male stratum
241202000,6,No prior metformin use
241202000,7,No prior insulin use or combo initiation
241200100,0,No prior with-in class exposure
241200100,1,No prior DPP4 inhibitor exposure
241200100,2,No prior SGLT-2 inhibitor exposure
241200100,3,No prior SU exposure
241200100,4,No prior other anti-diabetic exposure
241200100,5,Race stratum
241200100,6,No prior metformin use
241200100,7,No prior insulin use or combo initiation
241200001,0,No prior with-in class exposure
241200001,1,No prior DPP4 inhibitor exposure
241200001,2,No prior SGLT-2 inhibitor exposure
241200001,3,No prior SU exposure
241200001,4,No prior other anti-diabetic exposure
241200001,5,Without renal impairment
241200001,6,No prior metformin use
241200001,7,No prior insulin use or combo initiation
241200002,0,No prior with-in class exposure
241200002,1,No prior DPP4 inhibitor exposure
241200002,2,No prior SGLT-2 inhibitor exposure
241200002,3,No prior SU exposure
241200002,4,No prior other anti-diabetic exposure
241200002,5,Renal impairment
241200002,6,No prior metformin use
241200002,7,No prior insulin use or combo initiation
242200000,0,No prior with-in class exposure
242200000,1,No prior DPP4 inhibitor exposure
242200000,2,No prior SGLT-2 inhibitor exposure
242200000,3,No prior SU exposure
242200000,4,No prior other anti-diabetic exposure
242200000,5,No prior metformin use
242200000,6,No prior insulin use or combo initiation
242210000,0,No prior with-in class exposure
242210000,1,No prior DPP4 inhibitor exposure
242210000,2,No prior SGLT-2 inhibitor exposure
242210000,3,No prior SU exposure
242210000,4,No prior other anti-diabetic exposure
242210000,5,Lower age group
242210000,6,No prior metformin use
242210000,7,No prior insulin use or combo initiation
242220000,0,No prior with-in class exposure
242220000,1,No prior DPP4 inhibitor exposure
242220000,2,No prior SGLT-2 inhibitor exposure
242220000,3,No prior SU exposure
242220000,4,No prior other anti-diabetic exposure
242220000,5,Middle age group
242220000,6,No prior metformin use
242220000,7,No prior insulin use or combo initiation
242230000,0,No prior with-in class exposure
242230000,1,No prior DPP4 inhibitor exposure
242230000,2,No prior SGLT-2 inhibitor exposure
242230000,3,No prior SU exposure
242230000,4,No prior other anti-diabetic exposure
242230000,5,Older age group
242230000,6,No prior metformin use
242230000,7,No prior insulin use or combo initiation
242200010,0,No prior with-in class exposure
242200010,1,No prior DPP4 inhibitor exposure
242200010,2,No prior SGLT-2 inhibitor exposure
242200010,3,No prior SU exposure
242200010,4,No prior other anti-diabetic exposure
242200010,5,Low cardiovascular risk
242200010,6,No prior metformin use
242200010,7,No prior insulin use or combo initiation
242200020,0,No prior with-in class exposure
242200020,1,No prior DPP4 inhibitor exposure
242200020,2,No prior SGLT-2 inhibitor exposure
242200020,3,No prior SU exposure
242200020,4,No prior other anti-diabetic exposure
242200020,5,Higher cardiovascular risk
242200020,6,No prior metformin use
242200020,7,No prior insulin use or combo initiation
242201000,0,No prior with-in class exposure
242201000,1,No prior DPP4 inhibitor exposure
242201000,2,No prior SGLT-2 inhibitor exposure
242201000,3,No prior SU exposure
242201000,4,No prior other anti-diabetic exposure
242201000,5,Female stratum
242201000,6,No prior metformin use
242201000,7,No prior insulin use or combo initiation
242202000,0,No prior with-in class exposure
242202000,1,No prior DPP4 inhibitor exposure
242202000,2,No prior SGLT-2 inhibitor exposure
242202000,3,No prior SU exposure
242202000,4,No prior other anti-diabetic exposure
242202000,5,Male stratum
242202000,6,No prior metformin use
242202000,7,No prior insulin use or combo initiation
242200100,0,No prior with-in class exposure
242200100,1,No prior DPP4 inhibitor exposure
242200100,2,No prior SGLT-2 inhibitor exposure
242200100,3,No prior SU exposure
242200100,4,No prior other anti-diabetic exposure
242200100,5,Race stratum
242200100,6,No prior metformin use
242200100,7,No prior insulin use or combo initiation
242200001,0,No prior with-in class exposure
242200001,1,No prior DPP4 inhibitor exposure
242200001,2,No prior SGLT-2 inhibitor exposure
242200001,3,No prior SU exposure
242200001,4,No prior other anti-diabetic exposure
242200001,5,Without renal impairment
242200001,6,No prior metformin use
242200001,7,No prior insulin use or combo initiation
242200002,0,No prior with-in class exposure
242200002,1,No prior DPP4 inhibitor exposure
242200002,2,No prior SGLT-2 inhibitor exposure
242200002,3,No prior SU exposure
242200002,4,No prior other anti-diabetic exposure
242200002,5,Renal impairment
242200002,6,No prior metformin use
242200002,7,No prior insulin use or combo initiation
251100000,0,No prior with-in class exposure
251100000,1,No prior DPP4 inhibitor exposure
251100000,2,No prior SGLT-2 inhibitor exposure
251100000,3,No prior SU exposure
251100000,4,No prior other anti-diabetic exposure
251100000,5,Prior metformin use
251100000,6,No prior insulin use or combo initiation
251110000,0,No prior with-in class exposure
251110000,1,No prior DPP4 inhibitor exposure
251110000,2,No prior SGLT-2 inhibitor exposure
251110000,3,No prior SU exposure
251110000,4,No prior other anti-diabetic exposure
251110000,5,Lower age group
251110000,6,Prior metformin use
251110000,7,No prior insulin use or combo initiation
251120000,0,No prior with-in class exposure
251120000,1,No prior DPP4 inhibitor exposure
251120000,2,No prior SGLT-2 inhibitor exposure
251120000,3,No prior SU exposure
262120000,3,No prior SU exposure
251120000,4,No prior other anti-diabetic exposure
251120000,5,Middle age group
251120000,6,Prior metformin use
251120000,7,No prior insulin use or combo initiation
251130000,0,No prior with-in class exposure
251130000,1,No prior DPP4 inhibitor exposure
251130000,2,No prior SGLT-2 inhibitor exposure
251130000,3,No prior SU exposure
251130000,4,No prior other anti-diabetic exposure
251130000,5,Older age group
251130000,6,Prior metformin use
251130000,7,No prior insulin use or combo initiation
251100010,0,No prior with-in class exposure
251100010,1,No prior DPP4 inhibitor exposure
251100010,2,No prior SGLT-2 inhibitor exposure
251100010,3,No prior SU exposure
251100010,4,No prior other anti-diabetic exposure
251100010,5,Low cardiovascular risk
251100010,6,Prior metformin use
251100010,7,No prior insulin use or combo initiation
251100020,0,No prior with-in class exposure
251100020,1,No prior DPP4 inhibitor exposure
251100020,2,No prior SGLT-2 inhibitor exposure
251100020,3,No prior SU exposure
251100020,4,No prior other anti-diabetic exposure
251100020,5,Higher cardiovascular risk
251100020,6,Prior metformin use
251100020,7,No prior insulin use or combo initiation
251101000,0,No prior with-in class exposure
251101000,1,No prior DPP4 inhibitor exposure
251101000,2,No prior SGLT-2 inhibitor exposure
251101000,3,No prior SU exposure
251101000,4,No prior other anti-diabetic exposure
251101000,5,Female stratum
251101000,6,Prior metformin use
251101000,7,No prior insulin use or combo initiation
251102000,0,No prior with-in class exposure
251102000,1,No prior DPP4 inhibitor exposure
251102000,2,No prior SGLT-2 inhibitor exposure
251102000,3,No prior SU exposure
251102000,4,No prior other anti-diabetic exposure
251102000,5,Male stratum
251102000,6,Prior metformin use
251102000,7,No prior insulin use or combo initiation
251100100,0,No prior with-in class exposure
251100100,1,No prior DPP4 inhibitor exposure
251100100,2,No prior SGLT-2 inhibitor exposure
251100100,3,No prior SU exposure
251100100,4,No prior other anti-diabetic exposure
251100100,5,Race stratum
251100100,6,Prior metformin use
251100100,7,No prior insulin use or combo initiation
251100001,0,No prior with-in class exposure
251100001,1,No prior DPP4 inhibitor exposure
251100001,2,No prior SGLT-2 inhibitor exposure
251100001,3,No prior SU exposure
251100001,4,No prior other anti-diabetic exposure
251100001,5,Without renal impairment
251100001,6,Prior metformin use
251100001,7,No prior insulin use or combo initiation
251100002,0,No prior with-in class exposure
251100002,1,No prior DPP4 inhibitor exposure
251100002,2,No prior SGLT-2 inhibitor exposure
251100002,3,No prior SU exposure
251100002,4,No prior other anti-diabetic exposure
251100002,5,Renal impairment
251100002,6,Prior metformin use
251100002,7,No prior insulin use or combo initiation
252100000,0,No prior with-in class exposure
252100000,1,No prior DPP4 inhibitor exposure
252100000,2,No prior SGLT-2 inhibitor exposure
252100000,3,No prior SU exposure
252100000,4,No prior other anti-diabetic exposure
252100000,5,Prior metformin use
252100000,6,No prior insulin use or combo initiation
252110000,0,No prior with-in class exposure
252110000,1,No prior DPP4 inhibitor exposure
252110000,2,No prior SGLT-2 inhibitor exposure
252110000,3,No prior SU exposure
252110000,4,No prior other anti-diabetic exposure
252110000,5,Lower age group
252110000,6,Prior metformin use
252110000,7,No prior insulin use or combo initiation
252120000,0,No prior with-in class exposure
252120000,1,No prior DPP4 inhibitor exposure
252120000,2,No prior SGLT-2 inhibitor exposure
252120000,3,No prior SU exposure
252120000,4,No prior other anti-diabetic exposure
252120000,5,Middle age group
252120000,6,Prior metformin use
252120000,7,No prior insulin use or combo initiation
252130000,0,No prior with-in class exposure
252130000,1,No prior DPP4 inhibitor exposure
252130000,2,No prior SGLT-2 inhibitor exposure
252130000,3,No prior SU exposure
252130000,4,No prior other anti-diabetic exposure
252130000,5,Older age group
252130000,6,Prior metformin use
252130000,7,No prior insulin use or combo initiation
252100010,0,No prior with-in class exposure
252100010,1,No prior DPP4 inhibitor exposure
252100010,2,No prior SGLT-2 inhibitor exposure
252100010,3,No prior SU exposure
252100010,4,No prior other anti-diabetic exposure
252100010,5,Low cardiovascular risk
252100010,6,Prior metformin use
252100010,7,No prior insulin use or combo initiation
252100020,0,No prior with-in class exposure
252100020,1,No prior DPP4 inhibitor exposure
252100020,2,No prior SGLT-2 inhibitor exposure
252100020,3,No prior SU exposure
252100020,4,No prior other anti-diabetic exposure
252100020,5,Higher cardiovascular risk
252100020,6,Prior metformin use
252100020,7,No prior insulin use or combo initiation
252101000,0,No prior with-in class exposure
252101000,1,No prior DPP4 inhibitor exposure
252101000,2,No prior SGLT-2 inhibitor exposure
252101000,3,No prior SU exposure
252101000,4,No prior other anti-diabetic exposure
252101000,5,Female stratum
252101000,6,Prior metformin use
252101000,7,No prior insulin use or combo initiation
252102000,0,No prior with-in class exposure
252102000,1,No prior DPP4 inhibitor exposure
252102000,2,No prior SGLT-2 inhibitor exposure
252102000,3,No prior SU exposure
252102000,4,No prior other anti-diabetic exposure
252102000,5,Male stratum
252102000,6,Prior metformin use
252102000,7,No prior insulin use or combo initiation
252100100,0,No prior with-in class exposure
252100100,1,No prior DPP4 inhibitor exposure
252100100,2,No prior SGLT-2 inhibitor exposure
252100100,3,No prior SU exposure
252100100,4,No prior other anti-diabetic exposure
252100100,5,Race stratum
252100100,6,Prior metformin use
252100100,7,No prior insulin use or combo initiation
252100001,0,No prior with-in class exposure
252100001,1,No prior DPP4 inhibitor exposure
252100001,2,No prior SGLT-2 inhibitor exposure
252100001,3,No prior SU exposure
252100001,4,No prior other anti-diabetic exposure
252100001,5,Without renal impairment
252100001,6,Prior metformin use
252100001,7,No prior insulin use or combo initiation
252100002,0,No prior with-in class exposure
252100002,1,No prior DPP4 inhibitor exposure
252100002,2,No prior SGLT-2 inhibitor exposure
252100002,3,No prior SU exposure
252100002,4,No prior other anti-diabetic exposure
252100002,5,Renal impairment
252100002,6,Prior metformin use
252100002,7,No prior insulin use or combo initiation
251200000,0,No prior with-in class exposure
251200000,1,No prior DPP4 inhibitor exposure
251200000,2,No prior SGLT-2 inhibitor exposure
251200000,3,No prior SU exposure
251200000,4,No prior other anti-diabetic exposure
251200000,5,No prior metformin use
251200000,6,No prior insulin use or combo initiation
251210000,0,No prior with-in class exposure
251210000,1,No prior DPP4 inhibitor exposure
251210000,2,No prior SGLT-2 inhibitor exposure
251210000,3,No prior SU exposure
251210000,4,No prior other anti-diabetic exposure
251210000,5,Lower age group
251210000,6,No prior metformin use
251210000,7,No prior insulin use or combo initiation
251220000,0,No prior with-in class exposure
251220000,1,No prior DPP4 inhibitor exposure
251220000,2,No prior SGLT-2 inhibitor exposure
251220000,3,No prior SU exposure
251220000,4,No prior other anti-diabetic exposure
251220000,5,Middle age group
251220000,6,No prior metformin use
251220000,7,No prior insulin use or combo initiation
251230000,0,No prior with-in class exposure
251230000,1,No prior DPP4 inhibitor exposure
251230000,2,No prior SGLT-2 inhibitor exposure
251230000,3,No prior SU exposure
251230000,4,No prior other anti-diabetic exposure
251230000,5,Older age group
251230000,6,No prior metformin use
251230000,7,No prior insulin use or combo initiation
251200010,0,No prior with-in class exposure
251200010,1,No prior DPP4 inhibitor exposure
251200010,2,No prior SGLT-2 inhibitor exposure
251200010,3,No prior SU exposure
251200010,4,No prior other anti-diabetic exposure
251200010,5,Low cardiovascular risk
251200010,6,No prior metformin use
251200010,7,No prior insulin use or combo initiation
251200020,0,No prior with-in class exposure
251200020,1,No prior DPP4 inhibitor exposure
251200020,2,No prior SGLT-2 inhibitor exposure
251200020,3,No prior SU exposure
251200020,4,No prior other anti-diabetic exposure
251200020,5,Higher cardiovascular risk
251200020,6,No prior metformin use
251200020,7,No prior insulin use or combo initiation
251201000,0,No prior with-in class exposure
251201000,1,No prior DPP4 inhibitor exposure
251201000,2,No prior SGLT-2 inhibitor exposure
251201000,3,No prior SU exposure
251201000,4,No prior other anti-diabetic exposure
251201000,5,Female stratum
251201000,6,No prior metformin use
251201000,7,No prior insulin use or combo initiation
251202000,0,No prior with-in class exposure
251202000,1,No prior DPP4 inhibitor exposure
251202000,2,No prior SGLT-2 inhibitor exposure
251202000,3,No prior SU exposure
251202000,4,No prior other anti-diabetic exposure
251202000,5,Male stratum
251202000,6,No prior metformin use
251202000,7,No prior insulin use or combo initiation
251200100,0,No prior with-in class exposure
251200100,1,No prior DPP4 inhibitor exposure
251200100,2,No prior SGLT-2 inhibitor exposure
251200100,3,No prior SU exposure
251200100,4,No prior other anti-diabetic exposure
251200100,5,Race stratum
251200100,6,No prior metformin use
251200100,7,No prior insulin use or combo initiation
251200001,0,No prior with-in class exposure
251200001,1,No prior DPP4 inhibitor exposure
251200001,2,No prior SGLT-2 inhibitor exposure
251200001,3,No prior SU exposure
251200001,4,No prior other anti-diabetic exposure
251200001,5,Without renal impairment
251200001,6,No prior metformin use
251200001,7,No prior insulin use or combo initiation
251200002,0,No prior with-in class exposure
251200002,1,No prior DPP4 inhibitor exposure
251200002,2,No prior SGLT-2 inhibitor exposure
251200002,3,No prior SU exposure
251200002,4,No prior other anti-diabetic exposure
251200002,5,Renal impairment
251200002,6,No prior metformin use
251200002,7,No prior insulin use or combo initiation
252200000,0,No prior with-in class exposure
252200000,1,No prior DPP4 inhibitor exposure
252200000,2,No prior SGLT-2 inhibitor exposure
252200000,3,No prior SU exposure
252200000,4,No prior other anti-diabetic exposure
252200000,5,No prior metformin use
252200000,6,No prior insulin use or combo initiation
252210000,0,No prior with-in class exposure
252210000,1,No prior DPP4 inhibitor exposure
252210000,2,No prior SGLT-2 inhibitor exposure
252210000,3,No prior SU exposure
252210000,4,No prior other anti-diabetic exposure
252210000,5,Lower age group
252210000,6,No prior metformin use
252210000,7,No prior insulin use or combo initiation
252220000,0,No prior with-in class exposure
252220000,1,No prior DPP4 inhibitor exposure
252220000,2,No prior SGLT-2 inhibitor exposure
252220000,3,No prior SU exposure
252220000,4,No prior other anti-diabetic exposure
252220000,5,Middle age group
252220000,6,No prior metformin use
252220000,7,No prior insulin use or combo initiation
252230000,0,No prior with-in class exposure
252230000,1,No prior DPP4 inhibitor exposure
252230000,2,No prior SGLT-2 inhibitor exposure
252230000,3,No prior SU exposure
252230000,4,No prior other anti-diabetic exposure
252230000,5,Older age group
252230000,6,No prior metformin use
252230000,7,No prior insulin use or combo initiation
252200010,0,No prior with-in class exposure
252200010,1,No prior DPP4 inhibitor exposure
252200010,2,No prior SGLT-2 inhibitor exposure
252200010,3,No prior SU exposure
252200010,4,No prior other anti-diabetic exposure
252200010,5,Low cardiovascular risk
252200010,6,No prior metformin use
252200010,7,No prior insulin use or combo initiation
252200020,0,No prior with-in class exposure
252200020,1,No prior DPP4 inhibitor exposure
252200020,2,No prior SGLT-2 inhibitor exposure
252200020,3,No prior SU exposure
252200020,4,No prior other anti-diabetic exposure
252200020,5,Higher cardiovascular risk
252200020,6,No prior metformin use
252200020,7,No prior insulin use or combo initiation
252201000,0,No prior with-in class exposure
252201000,1,No prior DPP4 inhibitor exposure
252201000,2,No prior SGLT-2 inhibitor exposure
252201000,3,No prior SU exposure
252201000,4,No prior other anti-diabetic exposure
252201000,5,Female stratum
252201000,6,No prior metformin use
252201000,7,No prior insulin use or combo initiation
252202000,0,No prior with-in class exposure
252202000,1,No prior DPP4 inhibitor exposure
252202000,2,No prior SGLT-2 inhibitor exposure
252202000,3,No prior SU exposure
252202000,4,No prior other anti-diabetic exposure
252202000,5,Male stratum
252202000,6,No prior metformin use
252202000,7,No prior insulin use or combo initiation
252200100,0,No prior with-in class exposure
252200100,1,No prior DPP4 inhibitor exposure
252200100,2,No prior SGLT-2 inhibitor exposure
252200100,3,No prior SU exposure
252200100,4,No prior other anti-diabetic exposure
252200100,5,Race stratum
252200100,6,No prior metformin use
252200100,7,No prior insulin use or combo initiation
252200001,0,No prior with-in class exposure
252200001,1,No prior DPP4 inhibitor exposure
252200001,2,No prior SGLT-2 inhibitor exposure
252200001,3,No prior SU exposure
252200001,4,No prior other anti-diabetic exposure
252200001,5,Without renal impairment
252200001,6,No prior metformin use
252200001,7,No prior insulin use or combo initiation
252200002,0,No prior with-in class exposure
252200002,1,No prior DPP4 inhibitor exposure
252200002,2,No prior SGLT-2 inhibitor exposure
252200002,3,No prior SU exposure
252200002,4,No prior other anti-diabetic exposure
252200002,5,Renal impairment
252200002,6,No prior metformin use
252200002,7,No prior insulin use or combo initiation
261100000,0,No prior with-in class exposure
261100000,1,No prior DPP4 inhibitor exposure
261100000,2,No prior SGLT-2 inhibitor exposure
261100000,3,No prior SU exposure
261100000,4,No prior other anti-diabetic exposure
261100000,5,Prior metformin use
261100000,6,No prior insulin use or combo initiation
261110000,0,No prior with-in class exposure
261110000,1,No prior DPP4 inhibitor exposure
261110000,2,No prior SGLT-2 inhibitor exposure
261110000,3,No prior SU exposure
261110000,4,No prior other anti-diabetic exposure
261110000,5,Lower age group
261110000,6,Prior metformin use
261110000,7,No prior insulin use or combo initiation
261120000,0,No prior with-in class exposure
261120000,1,No prior DPP4 inhibitor exposure
261120000,2,No prior SGLT-2 inhibitor exposure
261120000,3,No prior SU exposure
261120000,4,No prior other anti-diabetic exposure
261120000,5,Middle age group
261120000,6,Prior metformin use
261120000,7,No prior insulin use or combo initiation
261130000,0,No prior with-in class exposure
261130000,1,No prior DPP4 inhibitor exposure
261130000,2,No prior SGLT-2 inhibitor exposure
261130000,3,No prior SU exposure
261130000,4,No prior other anti-diabetic exposure
261130000,5,Older age group
261130000,6,Prior metformin use
261130000,7,No prior insulin use or combo initiation
261100010,0,No prior with-in class exposure
261100010,1,No prior DPP4 inhibitor exposure
261100010,2,No prior SGLT-2 inhibitor exposure
261100010,3,No prior SU exposure
261100010,4,No prior other anti-diabetic exposure
261100010,5,Low cardiovascular risk
261100010,6,Prior metformin use
261100010,7,No prior insulin use or combo initiation
261100020,0,No prior with-in class exposure
261100020,1,No prior DPP4 inhibitor exposure
261100020,2,No prior SGLT-2 inhibitor exposure
261100020,3,No prior SU exposure
261100020,4,No prior other anti-diabetic exposure
261100020,5,Higher cardiovascular risk
261100020,6,Prior metformin use
261100020,7,No prior insulin use or combo initiation
261101000,0,No prior with-in class exposure
261101000,1,No prior DPP4 inhibitor exposure
261101000,2,No prior SGLT-2 inhibitor exposure
261101000,3,No prior SU exposure
261101000,4,No prior other anti-diabetic exposure
261101000,5,Female stratum
261101000,6,Prior metformin use
261101000,7,No prior insulin use or combo initiation
261102000,0,No prior with-in class exposure
261102000,1,No prior DPP4 inhibitor exposure
261102000,2,No prior SGLT-2 inhibitor exposure
261102000,3,No prior SU exposure
261102000,4,No prior other anti-diabetic exposure
261102000,5,Male stratum
261102000,6,Prior metformin use
261102000,7,No prior insulin use or combo initiation
261100100,0,No prior with-in class exposure
261100100,1,No prior DPP4 inhibitor exposure
261100100,2,No prior SGLT-2 inhibitor exposure
261100100,3,No prior SU exposure
261100100,4,No prior other anti-diabetic exposure
261100100,5,Race stratum
261100100,6,Prior metformin use
261100100,7,No prior insulin use or combo initiation
261100001,0,No prior with-in class exposure
261100001,1,No prior DPP4 inhibitor exposure
261100001,2,No prior SGLT-2 inhibitor exposure
261100001,3,No prior SU exposure
261100001,4,No prior other anti-diabetic exposure
261100001,5,Without renal impairment
261100001,6,Prior metformin use
261100001,7,No prior insulin use or combo initiation
261100002,0,No prior with-in class exposure
261100002,1,No prior DPP4 inhibitor exposure
261100002,2,No prior SGLT-2 inhibitor exposure
261100002,3,No prior SU exposure
261100002,4,No prior other anti-diabetic exposure
261100002,5,Renal impairment
261100002,6,Prior metformin use
261100002,7,No prior insulin use or combo initiation
262100000,0,No prior with-in class exposure
262100000,1,No prior DPP4 inhibitor exposure
262100000,2,No prior SGLT-2 inhibitor exposure
262100000,3,No prior SU exposure
262100000,4,No prior other anti-diabetic exposure
262100000,5,Prior metformin use
262100000,6,No prior insulin use or combo initiation
262110000,0,No prior with-in class exposure
262110000,1,No prior DPP4 inhibitor exposure
262110000,2,No prior SGLT-2 inhibitor exposure
262110000,3,No prior SU exposure
262110000,4,No prior other anti-diabetic exposure
262110000,5,Lower age group
262110000,6,Prior metformin use
262110000,7,No prior insulin use or combo initiation
262120000,0,No prior with-in class exposure
262120000,1,No prior DPP4 inhibitor exposure
262120000,2,No prior SGLT-2 inhibitor exposure
262120000,4,No prior other anti-diabetic exposure
262120000,5,Middle age group
262120000,6,Prior metformin use
262120000,7,No prior insulin use or combo initiation
262130000,0,No prior with-in class exposure
262130000,1,No prior DPP4 inhibitor exposure
262130000,2,No prior SGLT-2 inhibitor exposure
262130000,3,No prior SU exposure
262130000,4,No prior other anti-diabetic exposure
262130000,5,Older age group
262130000,6,Prior metformin use
262130000,7,No prior insulin use or combo initiation
262100010,0,No prior with-in class exposure
262100010,1,No prior DPP4 inhibitor exposure
262100010,2,No prior SGLT-2 inhibitor exposure
262100010,3,No prior SU exposure
262100010,4,No prior other anti-diabetic exposure
262100010,5,Low cardiovascular risk
262100010,6,Prior metformin use
262100010,7,No prior insulin use or combo initiation
262100020,0,No prior with-in class exposure
262100020,1,No prior DPP4 inhibitor exposure
262100020,2,No prior SGLT-2 inhibitor exposure
262100020,3,No prior SU exposure
262100020,4,No prior other anti-diabetic exposure
262100020,5,Higher cardiovascular risk
262100020,6,Prior metformin use
262100020,7,No prior insulin use or combo initiation
262101000,0,No prior with-in class exposure
262101000,1,No prior DPP4 inhibitor exposure
262101000,2,No prior SGLT-2 inhibitor exposure
262101000,3,No prior SU exposure
262101000,4,No prior other anti-diabetic exposure
262101000,5,Female stratum
262101000,6,Prior metformin use
262101000,7,No prior insulin use or combo initiation
262102000,0,No prior with-in class exposure
262102000,1,No prior DPP4 inhibitor exposure
262102000,2,No prior SGLT-2 inhibitor exposure
262102000,3,No prior SU exposure
262102000,4,No prior other anti-diabetic exposure
262102000,5,Male stratum
262102000,6,Prior metformin use
262102000,7,No prior insulin use or combo initiation
262100100,0,No prior with-in class exposure
262100100,1,No prior DPP4 inhibitor exposure
262100100,2,No prior SGLT-2 inhibitor exposure
262100100,3,No prior SU exposure
262100100,4,No prior other anti-diabetic exposure
262100100,5,Race stratum
262100100,6,Prior metformin use
262100100,7,No prior insulin use or combo initiation
262100001,0,No prior with-in class exposure
262100001,1,No prior DPP4 inhibitor exposure
262100001,2,No prior SGLT-2 inhibitor exposure
262100001,3,No prior SU exposure
262100001,4,No prior other anti-diabetic exposure
262100001,5,Without renal impairment
262100001,6,Prior metformin use
262100001,7,No prior insulin use or combo initiation
262100002,0,No prior with-in class exposure
262100002,1,No prior DPP4 inhibitor exposure
262100002,2,No prior SGLT-2 inhibitor exposure
262100002,3,No prior SU exposure
262100002,4,No prior other anti-diabetic exposure
262100002,5,Renal impairment
262100002,6,Prior metformin use
262100002,7,No prior insulin use or combo initiation
261200000,0,No prior with-in class exposure
261200000,1,No prior DPP4 inhibitor exposure
261200000,2,No prior SGLT-2 inhibitor exposure
261200000,3,No prior SU exposure
261200000,4,No prior other anti-diabetic exposure
261200000,5,No prior metformin use
261200000,6,No prior insulin use or combo initiation
261210000,0,No prior with-in class exposure
261210000,1,No prior DPP4 inhibitor exposure
261210000,2,No prior SGLT-2 inhibitor exposure
261210000,3,No prior SU exposure
261210000,4,No prior other anti-diabetic exposure
261210000,5,Lower age group
261210000,6,No prior metformin use
261210000,7,No prior insulin use or combo initiation
261220000,0,No prior with-in class exposure
261220000,1,No prior DPP4 inhibitor exposure
261220000,2,No prior SGLT-2 inhibitor exposure
261220000,3,No prior SU exposure
261220000,4,No prior other anti-diabetic exposure
261220000,5,Middle age group
261220000,6,No prior metformin use
261220000,7,No prior insulin use or combo initiation
261230000,0,No prior with-in class exposure
261230000,1,No prior DPP4 inhibitor exposure
261230000,2,No prior SGLT-2 inhibitor exposure
261230000,3,No prior SU exposure
261230000,4,No prior other anti-diabetic exposure
261230000,5,Older age group
261230000,6,No prior metformin use
261230000,7,No prior insulin use or combo initiation
261200010,0,No prior with-in class exposure
261200010,1,No prior DPP4 inhibitor exposure
261200010,2,No prior SGLT-2 inhibitor exposure
261200010,3,No prior SU exposure
261200010,4,No prior other anti-diabetic exposure
261200010,5,Low cardiovascular risk
261200010,6,No prior metformin use
261200010,7,No prior insulin use or combo initiation
261200020,0,No prior with-in class exposure
262202000,6,No prior metformin use
261200020,1,No prior DPP4 inhibitor exposure
261200020,2,No prior SGLT-2 inhibitor exposure
261200020,3,No prior SU exposure
261200020,4,No prior other anti-diabetic exposure
261200020,5,Higher cardiovascular risk
261200020,6,No prior metformin use
261200020,7,No prior insulin use or combo initiation
261201000,0,No prior with-in class exposure
261201000,1,No prior DPP4 inhibitor exposure
261201000,2,No prior SGLT-2 inhibitor exposure
261201000,3,No prior SU exposure
261201000,4,No prior other anti-diabetic exposure
261201000,5,Female stratum
261201000,6,No prior metformin use
261201000,7,No prior insulin use or combo initiation
261202000,0,No prior with-in class exposure
261202000,1,No prior DPP4 inhibitor exposure
261202000,2,No prior SGLT-2 inhibitor exposure
261202000,3,No prior SU exposure
261202000,4,No prior other anti-diabetic exposure
261202000,5,Male stratum
261202000,6,No prior metformin use
261202000,7,No prior insulin use or combo initiation
261200100,0,No prior with-in class exposure
261200100,1,No prior DPP4 inhibitor exposure
261200100,2,No prior SGLT-2 inhibitor exposure
261200100,3,No prior SU exposure
261200100,4,No prior other anti-diabetic exposure
261200100,5,Race stratum
261200100,6,No prior metformin use
261200100,7,No prior insulin use or combo initiation
261200001,0,No prior with-in class exposure
261200001,1,No prior DPP4 inhibitor exposure
261200001,2,No prior SGLT-2 inhibitor exposure
261200001,3,No prior SU exposure
261200001,4,No prior other anti-diabetic exposure
261200001,5,Without renal impairment
261200001,6,No prior metformin use
261200001,7,No prior insulin use or combo initiation
261200002,0,No prior with-in class exposure
261200002,1,No prior DPP4 inhibitor exposure
261200002,2,No prior SGLT-2 inhibitor exposure
261200002,3,No prior SU exposure
261200002,4,No prior other anti-diabetic exposure
261200002,5,Renal impairment
261200002,6,No prior metformin use
261200002,7,No prior insulin use or combo initiation
262200000,0,No prior with-in class exposure
262200000,1,No prior DPP4 inhibitor exposure
262200000,2,No prior SGLT-2 inhibitor exposure
262200000,3,No prior SU exposure
262200000,4,No prior other anti-diabetic exposure
262200000,5,No prior metformin use
262200000,6,No prior insulin use or combo initiation
262210000,0,No prior with-in class exposure
262210000,1,No prior DPP4 inhibitor exposure
262210000,2,No prior SGLT-2 inhibitor exposure
262210000,3,No prior SU exposure
262210000,4,No prior other anti-diabetic exposure
262210000,5,Lower age group
262210000,6,No prior metformin use
262210000,7,No prior insulin use or combo initiation
262220000,0,No prior with-in class exposure
262220000,1,No prior DPP4 inhibitor exposure
262220000,2,No prior SGLT-2 inhibitor exposure
262220000,3,No prior SU exposure
262220000,4,No prior other anti-diabetic exposure
262220000,5,Middle age group
262220000,6,No prior metformin use
262220000,7,No prior insulin use or combo initiation
262230000,0,No prior with-in class exposure
262230000,1,No prior DPP4 inhibitor exposure
262230000,2,No prior SGLT-2 inhibitor exposure
262230000,3,No prior SU exposure
262230000,4,No prior other anti-diabetic exposure
262230000,5,Older age group
262230000,6,No prior metformin use
262230000,7,No prior insulin use or combo initiation
262200010,0,No prior with-in class exposure
262200010,1,No prior DPP4 inhibitor exposure
262200010,2,No prior SGLT-2 inhibitor exposure
262200010,3,No prior SU exposure
262200010,4,No prior other anti-diabetic exposure
262200010,5,Low cardiovascular risk
262200010,6,No prior metformin use
262200010,7,No prior insulin use or combo initiation
262200020,0,No prior with-in class exposure
262200020,1,No prior DPP4 inhibitor exposure
262200020,2,No prior SGLT-2 inhibitor exposure
262200020,3,No prior SU exposure
262200020,4,No prior other anti-diabetic exposure
262200020,5,Higher cardiovascular risk
262200020,6,No prior metformin use
262200020,7,No prior insulin use or combo initiation
262201000,0,No prior with-in class exposure
262201000,1,No prior DPP4 inhibitor exposure
262201000,2,No prior SGLT-2 inhibitor exposure
262201000,3,No prior SU exposure
262201000,4,No prior other anti-diabetic exposure
262201000,5,Female stratum
262201000,6,No prior metformin use
262201000,7,No prior insulin use or combo initiation
262202000,0,No prior with-in class exposure
262202000,1,No prior DPP4 inhibitor exposure
262202000,2,No prior SGLT-2 inhibitor exposure
262202000,3,No prior SU exposure
262202000,4,No prior other anti-diabetic exposure
262202000,5,Male stratum
262202000,7,No prior insulin use or combo initiation
262200100,0,No prior with-in class exposure
262200100,1,No prior DPP4 inhibitor exposure
262200100,2,No prior SGLT-2 inhibitor exposure
262200100,3,No prior SU exposure
262200100,4,No prior other anti-diabetic exposure
262200100,5,Race stratum
262200100,6,No prior metformin use
262200100,7,No prior insulin use or combo initiation
262200001,0,No prior with-in class exposure
262200001,1,No prior DPP4 inhibitor exposure
262200001,2,No prior SGLT-2 inhibitor exposure
262200001,3,No prior SU exposure
262200001,4,No prior other anti-diabetic exposure
262200001,5,Without renal impairment
262200001,6,No prior metformin use
262200001,7,No prior insulin use or combo initiation
262200002,0,No prior with-in class exposure
262200002,1,No prior DPP4 inhibitor exposure
262200002,2,No prior SGLT-2 inhibitor exposure
262200002,3,No prior SU exposure
262200002,4,No prior other anti-diabetic exposure
262200002,5,Renal impairment
262200002,6,No prior metformin use
262200002,7,No prior insulin use or combo initiation
271100000,0,No prior with-in class exposure
271100000,1,No prior DPP4 inhibitor exposure
271100000,2,No prior SGLT-2 inhibitor exposure
271100000,3,No prior SU exposure
271100000,4,No prior other anti-diabetic exposure
271100000,5,Prior metformin use
271100000,6,No prior insulin use or combo initiation
271110000,0,No prior with-in class exposure
271110000,1,No prior DPP4 inhibitor exposure
271110000,2,No prior SGLT-2 inhibitor exposure
271110000,3,No prior SU exposure
271110000,4,No prior other anti-diabetic exposure
271110000,5,Lower age group
271110000,6,Prior metformin use
271110000,7,No prior insulin use or combo initiation
271120000,0,No prior with-in class exposure
271120000,1,No prior DPP4 inhibitor exposure
271120000,2,No prior SGLT-2 inhibitor exposure
271120000,3,No prior SU exposure
271120000,4,No prior other anti-diabetic exposure
271120000,5,Middle age group
271120000,6,Prior metformin use
271120000,7,No prior insulin use or combo initiation
271130000,0,No prior with-in class exposure
271130000,1,No prior DPP4 inhibitor exposure
271130000,2,No prior SGLT-2 inhibitor exposure
271130000,3,No prior SU exposure
271130000,4,No prior other anti-diabetic exposure
271130000,5,Older age group
271130000,6,Prior metformin use
271130000,7,No prior insulin use or combo initiation
271100010,0,No prior with-in class exposure
271100010,1,No prior DPP4 inhibitor exposure
271100010,2,No prior SGLT-2 inhibitor exposure
271100010,3,No prior SU exposure
271100010,4,No prior other anti-diabetic exposure
271100010,5,Low cardiovascular risk
271100010,6,Prior metformin use
271100010,7,No prior insulin use or combo initiation
271100020,0,No prior with-in class exposure
271100020,1,No prior DPP4 inhibitor exposure
271100020,2,No prior SGLT-2 inhibitor exposure
271100020,3,No prior SU exposure
271100020,4,No prior other anti-diabetic exposure
271100020,5,Higher cardiovascular risk
271100020,6,Prior metformin use
271100020,7,No prior insulin use or combo initiation
271101000,0,No prior with-in class exposure
271101000,1,No prior DPP4 inhibitor exposure
271101000,2,No prior SGLT-2 inhibitor exposure
271101000,3,No prior SU exposure
271101000,4,No prior other anti-diabetic exposure
271101000,5,Female stratum
271101000,6,Prior metformin use
271101000,7,No prior insulin use or combo initiation
271102000,0,No prior with-in class exposure
271102000,1,No prior DPP4 inhibitor exposure
271102000,2,No prior SGLT-2 inhibitor exposure
271102000,3,No prior SU exposure
271102000,4,No prior other anti-diabetic exposure
271102000,5,Male stratum
271102000,6,Prior metformin use
271102000,7,No prior insulin use or combo initiation
271100100,0,No prior with-in class exposure
271100100,1,No prior DPP4 inhibitor exposure
271100100,2,No prior SGLT-2 inhibitor exposure
271100100,3,No prior SU exposure
271100100,4,No prior other anti-diabetic exposure
271100100,5,Race stratum
271100100,6,Prior metformin use
271100100,7,No prior insulin use or combo initiation
271100001,0,No prior with-in class exposure
271100001,1,No prior DPP4 inhibitor exposure
271100001,2,No prior SGLT-2 inhibitor exposure
271100001,3,No prior SU exposure
271100001,4,No prior other anti-diabetic exposure
271100001,5,Without renal impairment
271100001,6,Prior metformin use
271100001,7,No prior insulin use or combo initiation
271100002,0,No prior with-in class exposure
271100002,1,No prior DPP4 inhibitor exposure
271100002,2,No prior SGLT-2 inhibitor exposure
271100002,3,No prior SU exposure
271100002,4,No prior other anti-diabetic exposure
271100002,5,Renal impairment
271100002,6,Prior metformin use
271100002,7,No prior insulin use or combo initiation
272100000,0,No prior with-in class exposure
272100000,1,No prior DPP4 inhibitor exposure
272100000,2,No prior SGLT-2 inhibitor exposure
272100000,3,No prior SU exposure
272100000,4,No prior other anti-diabetic exposure
272100000,5,Prior metformin use
272100000,6,No prior insulin use or combo initiation
272110000,0,No prior with-in class exposure
272110000,1,No prior DPP4 inhibitor exposure
272110000,2,No prior SGLT-2 inhibitor exposure
272110000,3,No prior SU exposure
272110000,4,No prior other anti-diabetic exposure
272110000,5,Lower age group
272110000,6,Prior metformin use
272110000,7,No prior insulin use or combo initiation
272120000,0,No prior with-in class exposure
272120000,1,No prior DPP4 inhibitor exposure
272120000,2,No prior SGLT-2 inhibitor exposure
272120000,3,No prior SU exposure
272120000,4,No prior other anti-diabetic exposure
272120000,5,Middle age group
272120000,6,Prior metformin use
272120000,7,No prior insulin use or combo initiation
272130000,0,No prior with-in class exposure
272130000,1,No prior DPP4 inhibitor exposure
272130000,2,No prior SGLT-2 inhibitor exposure
272130000,3,No prior SU exposure
272130000,4,No prior other anti-diabetic exposure
272130000,5,Older age group
272130000,6,Prior metformin use
272130000,7,No prior insulin use or combo initiation
272100010,0,No prior with-in class exposure
272100010,1,No prior DPP4 inhibitor exposure
272100010,2,No prior SGLT-2 inhibitor exposure
272100010,3,No prior SU exposure
272100010,4,No prior other anti-diabetic exposure
272100010,5,Low cardiovascular risk
272100010,6,Prior metformin use
272100010,7,No prior insulin use or combo initiation
272100020,0,No prior with-in class exposure
272100020,1,No prior DPP4 inhibitor exposure
272100020,2,No prior SGLT-2 inhibitor exposure
272100020,3,No prior SU exposure
272100020,4,No prior other anti-diabetic exposure
272100020,5,Higher cardiovascular risk
272100020,6,Prior metformin use
272100020,7,No prior insulin use or combo initiation
272101000,0,No prior with-in class exposure
272101000,1,No prior DPP4 inhibitor exposure
272101000,2,No prior SGLT-2 inhibitor exposure
272101000,3,No prior SU exposure
272101000,4,No prior other anti-diabetic exposure
272101000,5,Female stratum
272101000,6,Prior metformin use
272101000,7,No prior insulin use or combo initiation
272102000,0,No prior with-in class exposure
272102000,1,No prior DPP4 inhibitor exposure
272102000,2,No prior SGLT-2 inhibitor exposure
272102000,3,No prior SU exposure
272102000,4,No prior other anti-diabetic exposure
272102000,5,Male stratum
272102000,6,Prior metformin use
272102000,7,No prior insulin use or combo initiation
272100100,0,No prior with-in class exposure
272100100,1,No prior DPP4 inhibitor exposure
272100100,2,No prior SGLT-2 inhibitor exposure
272100100,3,No prior SU exposure
272100100,4,No prior other anti-diabetic exposure
272100100,5,Race stratum
272100100,6,Prior metformin use
272100100,7,No prior insulin use or combo initiation
272100001,0,No prior with-in class exposure
272100001,1,No prior DPP4 inhibitor exposure
272100001,2,No prior SGLT-2 inhibitor exposure
272100001,3,No prior SU exposure
272100001,4,No prior other anti-diabetic exposure
272100001,5,Without renal impairment
272100001,6,Prior metformin use
272100001,7,No prior insulin use or combo initiation
272100002,0,No prior with-in class exposure
272100002,1,No prior DPP4 inhibitor exposure
272100002,2,No prior SGLT-2 inhibitor exposure
272100002,3,No prior SU exposure
272100002,4,No prior other anti-diabetic exposure
272100002,5,Renal impairment
272100002,6,Prior metformin use
272100002,7,No prior insulin use or combo initiation
271200000,0,No prior with-in class exposure
271200000,1,No prior DPP4 inhibitor exposure
271200000,2,No prior SGLT-2 inhibitor exposure
271200000,3,No prior SU exposure
271200000,4,No prior other anti-diabetic exposure
271200000,5,No prior metformin use
271200000,6,No prior insulin use or combo initiation
271210000,0,No prior with-in class exposure
271210000,1,No prior DPP4 inhibitor exposure
271210000,2,No prior SGLT-2 inhibitor exposure
271210000,3,No prior SU exposure
271210000,4,No prior other anti-diabetic exposure
271210000,5,Lower age group
271210000,6,No prior metformin use
271210000,7,No prior insulin use or combo initiation
271220000,0,No prior with-in class exposure
271220000,1,No prior DPP4 inhibitor exposure
271220000,2,No prior SGLT-2 inhibitor exposure
271220000,3,No prior SU exposure
271220000,4,No prior other anti-diabetic exposure
271220000,5,Middle age group
271220000,6,No prior metformin use
271220000,7,No prior insulin use or combo initiation
271230000,0,No prior with-in class exposure
271230000,1,No prior DPP4 inhibitor exposure
271230000,2,No prior SGLT-2 inhibitor exposure
271230000,3,No prior SU exposure
271230000,4,No prior other anti-diabetic exposure
271230000,5,Older age group
271230000,6,No prior metformin use
271230000,7,No prior insulin use or combo initiation
271200010,0,No prior with-in class exposure
271200010,1,No prior DPP4 inhibitor exposure
271200010,2,No prior SGLT-2 inhibitor exposure
271200010,3,No prior SU exposure
271200010,4,No prior other anti-diabetic exposure
271200010,5,Low cardiovascular risk
271200010,6,No prior metformin use
271200010,7,No prior insulin use or combo initiation
271200020,0,No prior with-in class exposure
271200020,1,No prior DPP4 inhibitor exposure
271200020,2,No prior SGLT-2 inhibitor exposure
271200020,3,No prior SU exposure
271200020,4,No prior other anti-diabetic exposure
271200020,5,Higher cardiovascular risk
271200020,6,No prior metformin use
271200020,7,No prior insulin use or combo initiation
271201000,0,No prior with-in class exposure
271201000,1,No prior DPP4 inhibitor exposure
271201000,2,No prior SGLT-2 inhibitor exposure
271201000,3,No prior SU exposure
271201000,4,No prior other anti-diabetic exposure
271201000,5,Female stratum
271201000,6,No prior metformin use
271201000,7,No prior insulin use or combo initiation
271202000,0,No prior with-in class exposure
271202000,1,No prior DPP4 inhibitor exposure
271202000,2,No prior SGLT-2 inhibitor exposure
271202000,3,No prior SU exposure
271202000,4,No prior other anti-diabetic exposure
271202000,5,Male stratum
271202000,6,No prior metformin use
271202000,7,No prior insulin use or combo initiation
271200100,0,No prior with-in class exposure
271200100,1,No prior DPP4 inhibitor exposure
271200100,2,No prior SGLT-2 inhibitor exposure
271200100,3,No prior SU exposure
271200100,4,No prior other anti-diabetic exposure
271200100,5,Race stratum
271200100,6,No prior metformin use
271200100,7,No prior insulin use or combo initiation
271200001,0,No prior with-in class exposure
271200001,1,No prior DPP4 inhibitor exposure
271200001,2,No prior SGLT-2 inhibitor exposure
271200001,3,No prior SU exposure
271200001,4,No prior other anti-diabetic exposure
271200001,5,Without renal impairment
271200001,6,No prior metformin use
271200001,7,No prior insulin use or combo initiation
271200002,0,No prior with-in class exposure
271200002,1,No prior DPP4 inhibitor exposure
271200002,2,No prior SGLT-2 inhibitor exposure
271200002,3,No prior SU exposure
271200002,4,No prior other anti-diabetic exposure
271200002,5,Renal impairment
271200002,6,No prior metformin use
271200002,7,No prior insulin use or combo initiation
272200000,0,No prior with-in class exposure
272200000,1,No prior DPP4 inhibitor exposure
272200000,2,No prior SGLT-2 inhibitor exposure
272200000,3,No prior SU exposure
272200000,4,No prior other anti-diabetic exposure
272200000,5,No prior metformin use
272200000,6,No prior insulin use or combo initiation
272210000,0,No prior with-in class exposure
272210000,1,No prior DPP4 inhibitor exposure
272210000,2,No prior SGLT-2 inhibitor exposure
272210000,3,No prior SU exposure
272210000,4,No prior other anti-diabetic exposure
272210000,5,Lower age group
272210000,6,No prior metformin use
272210000,7,No prior insulin use or combo initiation
272220000,0,No prior with-in class exposure
272220000,1,No prior DPP4 inhibitor exposure
272220000,2,No prior SGLT-2 inhibitor exposure
272220000,3,No prior SU exposure
272220000,4,No prior other anti-diabetic exposure
272220000,5,Middle age group
272220000,6,No prior metformin use
272220000,7,No prior insulin use or combo initiation
272230000,0,No prior with-in class exposure
272230000,1,No prior DPP4 inhibitor exposure
272230000,2,No prior SGLT-2 inhibitor exposure
272230000,3,No prior SU exposure
272230000,4,No prior other anti-diabetic exposure
272230000,5,Older age group
272230000,6,No prior metformin use
272230000,7,No prior insulin use or combo initiation
272200010,0,No prior with-in class exposure
272200010,1,No prior DPP4 inhibitor exposure
272200010,2,No prior SGLT-2 inhibitor exposure
272200010,3,No prior SU exposure
272200010,4,No prior other anti-diabetic exposure
272200010,5,Low cardiovascular risk
272200010,6,No prior metformin use
272200010,7,No prior insulin use or combo initiation
272200020,0,No prior with-in class exposure
272200020,1,No prior DPP4 inhibitor exposure
272200020,2,No prior SGLT-2 inhibitor exposure
272200020,3,No prior SU exposure
272200020,4,No prior other anti-diabetic exposure
272200020,5,Higher cardiovascular risk
272200020,6,No prior metformin use
272200020,7,No prior insulin use or combo initiation
272201000,0,No prior with-in class exposure
272201000,1,No prior DPP4 inhibitor exposure
272201000,2,No prior SGLT-2 inhibitor exposure
272201000,3,No prior SU exposure
272201000,4,No prior other anti-diabetic exposure
272201000,5,Female stratum
272201000,6,No prior metformin use
272201000,7,No prior insulin use or combo initiation
272202000,0,No prior with-in class exposure
272202000,1,No prior DPP4 inhibitor exposure
272202000,2,No prior SGLT-2 inhibitor exposure
272202000,3,No prior SU exposure
272202000,4,No prior other anti-diabetic exposure
272202000,5,Male stratum
272202000,6,No prior metformin use
272202000,7,No prior insulin use or combo initiation
272200100,0,No prior with-in class exposure
272200100,1,No prior DPP4 inhibitor exposure
272200100,2,No prior SGLT-2 inhibitor exposure
272200100,3,No prior SU exposure
272200100,4,No prior other anti-diabetic exposure
272200100,5,Race stratum
272200100,6,No prior metformin use
272200100,7,No prior insulin use or combo initiation
272200001,0,No prior with-in class exposure
272200001,1,No prior DPP4 inhibitor exposure
272200001,2,No prior SGLT-2 inhibitor exposure
272200001,3,No prior SU exposure
272200001,4,No prior other anti-diabetic exposure
272200001,5,Without renal impairment
272200001,6,No prior metformin use
272200001,7,No prior insulin use or combo initiation
272200002,0,No prior with-in class exposure
272200002,1,No prior DPP4 inhibitor exposure
272200002,2,No prior SGLT-2 inhibitor exposure
272200002,3,No prior SU exposure
272200002,4,No prior other anti-diabetic exposure
272200002,5,Renal impairment
272200002,6,No prior metformin use
272200002,7,No prior insulin use or combo initiation
281100000,0,No prior with-in class exposure
281100000,1,No prior DPP4 inhibitor exposure
281100000,2,No prior SGLT-2 inhibitor exposure
281100000,3,No prior SU exposure
281100000,4,No prior other anti-diabetic exposure
281100000,5,Prior metformin use
281100000,6,No prior insulin use or combo initiation
281110000,0,No prior with-in class exposure
281110000,1,No prior DPP4 inhibitor exposure
281110000,2,No prior SGLT-2 inhibitor exposure
281110000,3,No prior SU exposure
281110000,4,No prior other anti-diabetic exposure
281110000,5,Lower age group
281110000,6,Prior metformin use
281110000,7,No prior insulin use or combo initiation
281120000,0,No prior with-in class exposure
281120000,1,No prior DPP4 inhibitor exposure
281120000,2,No prior SGLT-2 inhibitor exposure
281120000,3,No prior SU exposure
281120000,4,No prior other anti-diabetic exposure
281120000,5,Middle age group
281120000,6,Prior metformin use
281120000,7,No prior insulin use or combo initiation
281130000,0,No prior with-in class exposure
281130000,1,No prior DPP4 inhibitor exposure
281130000,2,No prior SGLT-2 inhibitor exposure
281130000,3,No prior SU exposure
281130000,4,No prior other anti-diabetic exposure
281130000,5,Older age group
281130000,6,Prior metformin use
281130000,7,No prior insulin use or combo initiation
281100010,0,No prior with-in class exposure
281100010,1,No prior DPP4 inhibitor exposure
281100010,2,No prior SGLT-2 inhibitor exposure
281100010,3,No prior SU exposure
281100010,4,No prior other anti-diabetic exposure
281100010,5,Low cardiovascular risk
281100010,6,Prior metformin use
281100010,7,No prior insulin use or combo initiation
281100020,0,No prior with-in class exposure
281100020,1,No prior DPP4 inhibitor exposure
281100020,2,No prior SGLT-2 inhibitor exposure
281100020,3,No prior SU exposure
281100020,4,No prior other anti-diabetic exposure
281100020,5,Higher cardiovascular risk
281100020,6,Prior metformin use
281100020,7,No prior insulin use or combo initiation
281101000,0,No prior with-in class exposure
281101000,1,No prior DPP4 inhibitor exposure
281101000,2,No prior SGLT-2 inhibitor exposure
281101000,3,No prior SU exposure
281101000,4,No prior other anti-diabetic exposure
281101000,5,Female stratum
281101000,6,Prior metformin use
281101000,7,No prior insulin use or combo initiation
281102000,0,No prior with-in class exposure
281102000,1,No prior DPP4 inhibitor exposure
281102000,2,No prior SGLT-2 inhibitor exposure
281102000,3,No prior SU exposure
281102000,4,No prior other anti-diabetic exposure
281102000,5,Male stratum
281102000,6,Prior metformin use
281102000,7,No prior insulin use or combo initiation
281100100,0,No prior with-in class exposure
281100100,1,No prior DPP4 inhibitor exposure
281100100,2,No prior SGLT-2 inhibitor exposure
281100100,3,No prior SU exposure
281100100,4,No prior other anti-diabetic exposure
281100100,5,Race stratum
281100100,6,Prior metformin use
281100100,7,No prior insulin use or combo initiation
281100001,0,No prior with-in class exposure
281100001,1,No prior DPP4 inhibitor exposure
281100001,2,No prior SGLT-2 inhibitor exposure
281100001,3,No prior SU exposure
281100001,4,No prior other anti-diabetic exposure
281100001,5,Without renal impairment
281100001,6,Prior metformin use
281100001,7,No prior insulin use or combo initiation
281100002,0,No prior with-in class exposure
281100002,1,No prior DPP4 inhibitor exposure
281100002,2,No prior SGLT-2 inhibitor exposure
281100002,3,No prior SU exposure
281100002,4,No prior other anti-diabetic exposure
281100002,5,Renal impairment
281100002,6,Prior metformin use
281100002,7,No prior insulin use or combo initiation
282100000,0,No prior with-in class exposure
282100000,1,No prior DPP4 inhibitor exposure
282100000,2,No prior SGLT-2 inhibitor exposure
282100000,3,No prior SU exposure
282100000,4,No prior other anti-diabetic exposure
282100000,5,Prior metformin use
282100000,6,No prior insulin use or combo initiation
282110000,0,No prior with-in class exposure
282110000,1,No prior DPP4 inhibitor exposure
282110000,2,No prior SGLT-2 inhibitor exposure
282110000,3,No prior SU exposure
282110000,4,No prior other anti-diabetic exposure
282110000,5,Lower age group
282110000,6,Prior metformin use
282110000,7,No prior insulin use or combo initiation
282120000,0,No prior with-in class exposure
282120000,1,No prior DPP4 inhibitor exposure
282120000,2,No prior SGLT-2 inhibitor exposure
282120000,3,No prior SU exposure
282120000,4,No prior other anti-diabetic exposure
282120000,5,Middle age group
282120000,6,Prior metformin use
282120000,7,No prior insulin use or combo initiation
282130000,0,No prior with-in class exposure
282130000,1,No prior DPP4 inhibitor exposure
282130000,2,No prior SGLT-2 inhibitor exposure
282130000,3,No prior SU exposure
282130000,4,No prior other anti-diabetic exposure
282130000,5,Older age group
282130000,6,Prior metformin use
282130000,7,No prior insulin use or combo initiation
282100010,0,No prior with-in class exposure
282100010,1,No prior DPP4 inhibitor exposure
282100010,2,No prior SGLT-2 inhibitor exposure
282100010,3,No prior SU exposure
282100010,4,No prior other anti-diabetic exposure
282100010,5,Low cardiovascular risk
282100010,6,Prior metformin use
282100010,7,No prior insulin use or combo initiation
282100020,0,No prior with-in class exposure
282100020,1,No prior DPP4 inhibitor exposure
282100020,2,No prior SGLT-2 inhibitor exposure
282100020,3,No prior SU exposure
282100020,4,No prior other anti-diabetic exposure
282100020,5,Higher cardiovascular risk
282100020,6,Prior metformin use
282100020,7,No prior insulin use or combo initiation
282101000,0,No prior with-in class exposure
282101000,1,No prior DPP4 inhibitor exposure
282101000,2,No prior SGLT-2 inhibitor exposure
282101000,3,No prior SU exposure
282101000,4,No prior other anti-diabetic exposure
282101000,5,Female stratum
282101000,6,Prior metformin use
282101000,7,No prior insulin use or combo initiation
282102000,0,No prior with-in class exposure
282102000,1,No prior DPP4 inhibitor exposure
282102000,2,No prior SGLT-2 inhibitor exposure
282102000,3,No prior SU exposure
282102000,4,No prior other anti-diabetic exposure
282102000,5,Male stratum
282102000,6,Prior metformin use
282102000,7,No prior insulin use or combo initiation
282100100,0,No prior with-in class exposure
282100100,1,No prior DPP4 inhibitor exposure
282100100,2,No prior SGLT-2 inhibitor exposure
282100100,3,No prior SU exposure
282100100,4,No prior other anti-diabetic exposure
282100100,5,Race stratum
282100100,6,Prior metformin use
282100100,7,No prior insulin use or combo initiation
282100001,0,No prior with-in class exposure
282100001,1,No prior DPP4 inhibitor exposure
282100001,2,No prior SGLT-2 inhibitor exposure
282100001,3,No prior SU exposure
282100001,4,No prior other anti-diabetic exposure
282100001,5,Without renal impairment
282100001,6,Prior metformin use
282100001,7,No prior insulin use or combo initiation
282100002,0,No prior with-in class exposure
282100002,1,No prior DPP4 inhibitor exposure
282100002,2,No prior SGLT-2 inhibitor exposure
282100002,3,No prior SU exposure
282100002,4,No prior other anti-diabetic exposure
282100002,5,Renal impairment
282100002,6,Prior metformin use
282100002,7,No prior insulin use or combo initiation
281200000,0,No prior with-in class exposure
281200000,1,No prior DPP4 inhibitor exposure
281200000,2,No prior SGLT-2 inhibitor exposure
281200000,3,No prior SU exposure
281200000,4,No prior other anti-diabetic exposure
281200000,5,No prior metformin use
281200000,6,No prior insulin use or combo initiation
281210000,0,No prior with-in class exposure
281210000,1,No prior DPP4 inhibitor exposure
281210000,2,No prior SGLT-2 inhibitor exposure
281210000,3,No prior SU exposure
281210000,4,No prior other anti-diabetic exposure
281210000,5,Lower age group
281210000,6,No prior metformin use
281210000,7,No prior insulin use or combo initiation
281220000,0,No prior with-in class exposure
281220000,1,No prior DPP4 inhibitor exposure
281220000,2,No prior SGLT-2 inhibitor exposure
281220000,3,No prior SU exposure
281220000,4,No prior other anti-diabetic exposure
281220000,5,Middle age group
281220000,6,No prior metformin use
281220000,7,No prior insulin use or combo initiation
281230000,0,No prior with-in class exposure
281230000,1,No prior DPP4 inhibitor exposure
281230000,2,No prior SGLT-2 inhibitor exposure
281230000,3,No prior SU exposure
281230000,4,No prior other anti-diabetic exposure
281230000,5,Older age group
281230000,6,No prior metformin use
281230000,7,No prior insulin use or combo initiation
281200010,0,No prior with-in class exposure
281200010,1,No prior DPP4 inhibitor exposure
281200010,2,No prior SGLT-2 inhibitor exposure
281200010,3,No prior SU exposure
281200010,4,No prior other anti-diabetic exposure
281200010,5,Low cardiovascular risk
281200010,6,No prior metformin use
281200010,7,No prior insulin use or combo initiation
281200020,0,No prior with-in class exposure
281200020,1,No prior DPP4 inhibitor exposure
281200020,2,No prior SGLT-2 inhibitor exposure
281200020,3,No prior SU exposure
281200020,4,No prior other anti-diabetic exposure
281200020,5,Higher cardiovascular risk
281200020,6,No prior metformin use
281200020,7,No prior insulin use or combo initiation
281201000,0,No prior with-in class exposure
281201000,1,No prior DPP4 inhibitor exposure
281201000,2,No prior SGLT-2 inhibitor exposure
281201000,3,No prior SU exposure
281201000,4,No prior other anti-diabetic exposure
281201000,5,Female stratum
281201000,6,No prior metformin use
281201000,7,No prior insulin use or combo initiation
281202000,0,No prior with-in class exposure
281202000,1,No prior DPP4 inhibitor exposure
281202000,2,No prior SGLT-2 inhibitor exposure
281202000,3,No prior SU exposure
281202000,4,No prior other anti-diabetic exposure
281202000,5,Male stratum
281202000,6,No prior metformin use
281202000,7,No prior insulin use or combo initiation
281200100,0,No prior with-in class exposure
281200100,1,No prior DPP4 inhibitor exposure
281200100,2,No prior SGLT-2 inhibitor exposure
281200100,3,No prior SU exposure
281200100,4,No prior other anti-diabetic exposure
281200100,5,Race stratum
281200100,6,No prior metformin use
281200100,7,No prior insulin use or combo initiation
281200001,0,No prior with-in class exposure
281200001,1,No prior DPP4 inhibitor exposure
281200001,2,No prior SGLT-2 inhibitor exposure
281200001,3,No prior SU exposure
281200001,4,No prior other anti-diabetic exposure
281200001,5,Without renal impairment
281200001,6,No prior metformin use
281200001,7,No prior insulin use or combo initiation
281200002,0,No prior with-in class exposure
281200002,1,No prior DPP4 inhibitor exposure
281200002,2,No prior SGLT-2 inhibitor exposure
281200002,3,No prior SU exposure
281200002,4,No prior other anti-diabetic exposure
281200002,5,Renal impairment
281200002,6,No prior metformin use
281200002,7,No prior insulin use or combo initiation
282200000,0,No prior with-in class exposure
282200000,1,No prior DPP4 inhibitor exposure
282200000,2,No prior SGLT-2 inhibitor exposure
282200000,3,No prior SU exposure
282200000,4,No prior other anti-diabetic exposure
282200000,5,No prior metformin use
282200000,6,No prior insulin use or combo initiation
282210000,0,No prior with-in class exposure
282210000,1,No prior DPP4 inhibitor exposure
282210000,2,No prior SGLT-2 inhibitor exposure
282210000,3,No prior SU exposure
282210000,4,No prior other anti-diabetic exposure
282210000,5,Lower age group
282210000,6,No prior metformin use
282210000,7,No prior insulin use or combo initiation
282220000,0,No prior with-in class exposure
282220000,1,No prior DPP4 inhibitor exposure
282220000,2,No prior SGLT-2 inhibitor exposure
282220000,3,No prior SU exposure
282220000,4,No prior other anti-diabetic exposure
282220000,5,Middle age group
282220000,6,No prior metformin use
282220000,7,No prior insulin use or combo initiation
282230000,0,No prior with-in class exposure
282230000,1,No prior DPP4 inhibitor exposure
282230000,2,No prior SGLT-2 inhibitor exposure
282230000,3,No prior SU exposure
282230000,4,No prior other anti-diabetic exposure
282230000,5,Older age group
282230000,6,No prior metformin use
282230000,7,No prior insulin use or combo initiation
282200010,0,No prior with-in class exposure
282200010,1,No prior DPP4 inhibitor exposure
282200010,2,No prior SGLT-2 inhibitor exposure
282200010,3,No prior SU exposure
282200010,4,No prior other anti-diabetic exposure
282200010,5,Low cardiovascular risk
282200010,6,No prior metformin use
282200010,7,No prior insulin use or combo initiation
282200020,0,No prior with-in class exposure
282200020,1,No prior DPP4 inhibitor exposure
282200020,2,No prior SGLT-2 inhibitor exposure
282200020,3,No prior SU exposure
282200020,4,No prior other anti-diabetic exposure
282200020,5,Higher cardiovascular risk
282200020,6,No prior metformin use
282200020,7,No prior insulin use or combo initiation
282201000,0,No prior with-in class exposure
282201000,1,No prior DPP4 inhibitor exposure
282201000,2,No prior SGLT-2 inhibitor exposure
282201000,3,No prior SU exposure
282201000,4,No prior other anti-diabetic exposure
282201000,5,Female stratum
282201000,6,No prior metformin use
282201000,7,No prior insulin use or combo initiation
282202000,0,No prior with-in class exposure
282202000,1,No prior DPP4 inhibitor exposure
282202000,2,No prior SGLT-2 inhibitor exposure
282202000,3,No prior SU exposure
282202000,4,No prior other anti-diabetic exposure
282202000,5,Male stratum
282202000,6,No prior metformin use
282202000,7,No prior insulin use or combo initiation
282200100,0,No prior with-in class exposure
282200100,1,No prior DPP4 inhibitor exposure
282200100,2,No prior SGLT-2 inhibitor exposure
282200100,3,No prior SU exposure
282200100,4,No prior other anti-diabetic exposure
282200100,5,Race stratum
282200100,6,No prior metformin use
282200100,7,No prior insulin use or combo initiation
282200001,0,No prior with-in class exposure
282200001,1,No prior DPP4 inhibitor exposure
282200001,2,No prior SGLT-2 inhibitor exposure
282200001,3,No prior SU exposure
282200001,4,No prior other anti-diabetic exposure
282200001,5,Without renal impairment
282200001,6,No prior metformin use
282200001,7,No prior insulin use or combo initiation
282200002,0,No prior with-in class exposure
282200002,1,No prior DPP4 inhibitor exposure
282200002,2,No prior SGLT-2 inhibitor exposure
282200002,3,No prior SU exposure
282200002,4,No prior other anti-diabetic exposure
282200002,5,Renal impairment
282200002,6,No prior metformin use
282200002,7,No prior insulin use or combo initiation
